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Abstract 
The human immunodeficiem .. -y virus (HIV) and its latter stage, the acquired immune 
deficiency syndrome (AIDS), are still a major health problem in the world and the full 
<lX!ent of the epidentic is unknown. The IllY virus in Australia has been spread mainly 
through homosexual contact, but this mode of transmission is decreasing while 
transmission from heterosexual contact and from IV drug use is increasing. The 
proposed mathematical model concentrates on transntission of the HIV virus through 
heterosexual contact and IV drug u;e among heterosexuals in Western Australia. The 
model parameters will be estimated from surveys conducted by the Australian National 
Injecting Drug Use Study 1989-1991. The estimated parameters will be incorporated 
into the developed model and used in conjunction with co~'tputer simulations to study 
the spread of IllY and its progression to AIDS in Western Australian heterosexuals. 
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Preface 
The figures found in Appendix 4 have been labelled using the following code : 
I : The number of intravenous drug users which are infected with the HIV virus and 
have not developed AIDS. 
N : The number of non-intravenous drug users which are infected with the HIV virus 
and have not developed AIDS. 
C : The average percentage of time condoms are used. 
P : The average rrumber of n<..-:dle sharing 'partners· which an intravenous drug user 
has in a year. 
e I f : The results are provided for both 'e' and 'f values for the purpose of a 
comparison between the two. 
g (94) : The results are provided for when the original value for condom usage or 
needle sharing 'partners' was changed to 'g' in 1994. 
Therefore Figure A4.22 : I, C = 16.5, P = 1.6 I C = 35.5, P = I. is the number of 
living intravenous drug users that are infected with the HIV virus and have not 
progressed to AIDS given that in one instan<:e condoms are used on average I 6.5% of 
the time and IVDUs had on average 1.6 needlo sharing 'partners' in a year and in the 
second instance condoms are used on average 35.5% of the time and IVDUs had on 
average I needle sharing 'partner' in a year. 
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1. HIV and AIDS 
1.1 Background to HIV and AIDS 
The human immunodeficiency virus (lUV) was first identified in the United States of 
America in 198 I when the US Centers for Disease Control reported 5 cases of a 
young gay man in Los Angeles suffering from a rare pneumonia, pneumcx.ystis carinii 
pneumonia. Another ten cases of the rare pneumonia were reported in Los Angeles, 
New Y ark and San Francisco a month later as w.U as 26 CMes of Kaposi's sarcoma. 
The first case definition of the acquired immune deficiency syndrome (AIDS) was 
published in September 1982 (Elford et a!, 1991 ). 
The HIV vims is contracted through contact with body fluids infected with the virus. 
The virus can be isolated from various body fluids such as blood, semen, cervical and 
vaginal secretions, tissues, saliva, breast milk and tears of an infected individual. Tears 
and saliva are the only body fluids thst hsve not transmitted the HIV virus. Breast 
milk hss not definitely been identified as being responsible in the transmission of the 
virus, but hss been assumed to be possible of transmission. Non sexual social contact 
and insects do not transmit the virus (Nation Health and Medical Research Council, 
1990). 
The HIV virus affects the immune system of the infected individuals making them 
suxeptible to other diseases. h is when the individuals show the symptoms of these 
'opportunistic' infections that they are diagnosed as hsving the >cquired immune 
deficiency syndrome (AIDS). 
The United States Centers for Disease Control in January 1993 revised the case 
definition for AIDS. The revised case definition of AIDS provides a more accurate 
description of severe cases of HIV-related immunodeficiency. Both Australia and 
Europe have decided to follow only the second point of the revised definition. In 
Australia this new case definition is effective from I January 1993 (National Centre in 
HIV Epidemiology and Cfinical Research, 1993). Appendix I provides the case 
definition of AIDS developed by the Centers for Disease Control as of 1987. 
The revised definition of AIDS includes the following two points as described by the 
National Centre in HIV Epidemiology and Cfinical Research, page 8, 1993. 
"(i) adults and adolescents with diagnosed HIV infection who have a 
CD4+T-lymphocyte count of less than 200ul of blood or a CD4+T-
Iymphocyte percentage ofless than 14, with or without the diagnosis 
of disease(s) indicative of a defect in cell-mediated immunity, and (ii) 
pulmonary tuberculosis, recurrent pneumonia and invasive cervical 
cancer as AIDS-defining conditions. All AIDS-defining conditions 
included in the 1987 case definition are retained in the 1993 
definition." 
1.2 Global Pattems 
There are three main global patterns of spread of the HIV virus. The first pattern, 
which fits western industrialised world countries, describes the epidemic as starting in 
the late 1970's to early 1980's. The virus has affected mainly homosexual I bisexual 
individuals as well as inttavenous drug users. Small numbers of heterosexuals have 
been infected and the male to female ratio in approximately I O: I. Infection from blood 
products is under control through screening programs (Sato, et al, 1989). 
Pattern Two, which fits countries in the Caribbean and sub-Ssharan Aftica, describes 
the epidemic as starting in the late 1970's to early 1980's. The main mode of infection 
is through heterosexual contact, thereby providing a male to female ratio of 
approximately I: I and also high numbers of perinatal cases. Infection from 
2 
contaminated blood products is still significant as there is no adequate screening 
program (Sato, et al, 1989). 
Pattern Three fits communist bloc countries and those which up until the last few years 
were predominantly communist. The spread of the mv virus staned in the early to 
mid 1980's and occurred in all risk groups. The main mode of infection was in people 
travelling to high risk area• and contracting the disease (Sato, et al, 1989). 
1.3 HIV and AIDS in Australia 
The fitS! recorded AIDS case in Australia occurred in December of 1982 in Sydney 
(Kaldor et al, 1993). The individual contracted the virus from homosexual contact 
while in the U.S.A. Since then the number of new AIDS cases in Australia has been 
increasing with 692 cases in 1992 and 231 Cll!es in the first six months of 1993, 
making a total of 4258 reported AIDS csses from 1982 to the eod of March 1993 
(National Centre in lllV Epidemiology and Clinical Research, 1993). 
By 30 June 1992, 36 AIDS cases were reported to be diagnosed in January 1992. By 
31 March 1993, there were 50 reported cases of AIDS being diagnosed for the same 
month. Therefore 14 cases were reported at least 5 months after diagnosis. Another 2 
casea diagnosed in January 1992 were reported by 30 June 1993, at least 14 months 
after fitS! diagnosis (National Centre in lUV Epidemiology and Clinical Research, July 
1992, July 1993, October 1993). 
At least 206 AIDS cases reported by June 1993 for diagnosis in the first 6 months of 
1992 were not reported in the month they were diagnosed. These delayed reported 
casea more than doubled the number, for those months, of diagnosed AIDS cases 
3 
reported to 30 June 1992 (National Centre m lllV Epidemiology and Clinical 
Research, July 1992, October 1993). 
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Figure 1.1: Number of new and cumulative AIDS cases in Australia by year of 
diagnosis, 1983 to 30 June 1993. 
* * 1993 is incomplete. 
Figure l.l is based upon Table 1.1 below and shows the growth in the number of 
diagnosed AIDS cases in Australia each year up to the end of June 1993. Although it 
appears that the number of new AIDS cases diagnosed each year is starting to decline, 
delays in diagnosis can increase the statistics for some years. This is demonstrated in 
Table 1.1 where a comparison of the Australian lllV Surveillance Reports for July 
1992 and October 1993 is provided. The difference in Table 1.1 is for delays in 
diagnosis only as the data is incomplete for each year of the reports being published. 
The difference shows that there are long reporting delays of diagnosis of AIDS for 
recent years and until they are reported they can give a false impression of a reduction 
in the number of new AIDS cases. 
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Table 1.1: Number of new and cumulative AIDS cases in Australia by year of 
diaJmosis, 1983 to 30 June 1993. 
NUMBER OF AIDS CASES 
YEAR To June 1992 •I To June 1993 •2 DIFFERENCE •3 
NEW CUMULATIVE NEW CUMULATIVE NEW CUMULATIVE 
1982 I 1 I 1 0 0 
1983 6 7 6 7 0 0 
1984 46 53 46 53 0 0 
1985 126 179 127 180 I 1 
1986 227 406 227 407 0 1 
1987 376 782 381 788 5 6 
1988 527 1309 531 1319 4 10 
1989 582 1891 600 1919 18 28 
1990 633 2524 653 2572 20 48 
1991 670 3194 763 3335 93 141 
1992# 174 3368 692 4027 206 347 
1993# 231 4258 
•I (National Centre in IllY Epidemiology and Clinical Research, July 1992, Table 
1.8, page 12). 
•2 (National Centre in IllY Epidemiology and Clinical Research, October 1993, 
Table 4.8, page 13). 
,3 Delays in diagnosis where the cases were reported after 30 June 1992 and before 
30 June 1993, but occured before I July 1992. 
# 1992 and 1993 values are incomplete. 
Between 30 June 1992 and 30 June 1993, a total of347 AIDS cases were reported 
after delays ranging from a few months to nearly 8 years. Most of the delays between 
diagnosis and reporting of the case are 1 to 2 years (National Centre ir. mv 
Epidemiology and Clinical Research, July 1992, July 1993, October 1993 ). 
By the end of June 1993, there were 17475 reported cases of HIY infection in 
Australia. Homosexual/bisexual contact accounted for 82.4% of known transmissio:t 
of infection of the IllY virus among adults 13 years or over at the time of diagnosis. 
IV drug use and heterosexual contact accounted for 4.9"/o and 6.5% of known modes 
of transmission of adults 13 years and over at the time of diagnosis, respectively 
5 
(National Centre in HIV Epidemiology and Clinical Research, October 1993). Figure 
1.2 shows the number of adults infected via these modes of transmission of the HIV 
virus and the percentages. 
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Figure 1.2: Mode of transmission for HIV infection in Australia to 30 June 1993, for 
all individuals infected over 13 years at diagnosis ofHIV. 
(National Centre in lllV Epidemiology and Clinical Research, October 1993, Table 
2.2, page 20). 
By 30 June 1993 there were 10653 adolescents and adults 13 years and over 
diagnosed as being infected with the lllV virus and whose mode of transmission was 
known. Children under the age of 13 years whose mode of transmission was known, 
accounted for 94 cases of diagnosed lllV infection and there were 6728 cases where 
the mode of transmission was not determined or is classified as 'other'. 32 of these 
other I undetermined cases were of children and 86 cases of the total of 6728 other I 
undetermined cases were reported between 30 June 1992 and 30 June 1993 (National 
Centre in HIV Epidemiology and Clinical Research, July 1992, October 1993). 
Table 1.2 shows the number and percentage of males and females that were diagnosed 
as being HIV positive to the 31 March 1993. The ratio of male to female shows that 
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even among children under the age of 13 yoars the number of diagnoses of HIV is 
much higher in males than females. The high male to female ratio is expected among 
the adult cases of HIV diagnosis due to the high oumber of male homosexuals and 
bisexuals infected, the male to female ratio ofHIV diagnosis among children would be 
expected to be equal except for the high munber of baemophiliacs infected. Over half 
of the reported diagnosed cases of HIV infection among children under the age of 13 
years were through this disorder which affects mostly males. 
Table 1.2: Number and percentage of cumulative diagnosis of HIV infection in 
Australia by sex, to 31 March 1993. 
CATEGORY MALE FEMALE OTIIER#I TOTAL RATI0#3 
ADOLESCENT 10168 457 28 10653 95.4: 4.3: 0.3 
I ADULT (58.18%) (2.62%) (0.16%) (60.%%) 
CHILD 76 IS 3 94 80.8:16.0: 3.2 
<13YEARS (0.43%) (0.09"/o) (0.02%) (0.54%) 
OTHER#2 4334 311 2083 6728 64.4:4.6: J t.O 
(24.80%) (1.78%) (11.92%) (38.50%) 
TafAL 14578 783 2114 17475 83.4:4.5: 12.1 
(83.41%) (4.49"!.) (12.1%) (100%) 
(National Centre in HIV Epidemiology and Clinical Research, July 1993, Table 2.2, 
page 20). 
# 1 Sex was not reported or reported as transsexual. 
#2 Other or undetermined mode of transmission. 
#3 Ratio of male to female to 'other #I• for the cumulative number of diagnosed 
HIV infection in Australia. 
Table 1.3 shows the numbers and rates of diagnosis per I 00000 total current 
population oflllV infection and AIDS cases for all States and Territories of Australia. 
The Table shows that the total number of di•gnosed cases ofHIV infection and AIDS 
is not reflective on the incidence of AIDS and HIV cases within the population. 
Figures 1.3 and 1.4 are based upon Table 1.3 and clearly show the differences between 
the cumulative number of HIV cases and rate of lllV diagnosis per I 00000 total 
population among the States and territories of Australia. 
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Table 1.3: CumJiative number and rate of diagnosis of HIV infection and AIDS in 
Australia by State/ Territory to 30 June 1993. 
STATE/ HIV INFECTION A!DSCASES 
11lRRITORY NUMBER %Nl RATE#2 NUf-JBER %#1 RATE#2 
--
ACT 148 0.9'/o 50.3 54 1.3% 18.4 
NSW 11649 66.7% 195.5 2502 58.8% 42.0 
NT 73 0.4% 43.7 17 0.4% 10.2 
QLD 1280 7.3% 42.2 375 8.8% 12.4 
SA 547 3.1% 37.6 174 4.1% 12.0 
TAS 68 0.4% 14.5 26 0.6% 5.5 
VIC 3048 17.4% 68.5 918 21.5% 20.6 
WA 662 3.8% 40.0 192 4.5% 11.6 
TOTAL 17475 100% 100.0 4258 100% 24.4 
(National Ceotre in IDV Epid.miology and Clinical Research. October 1993. Tables 
4.1, 4.2 and 5.1, pages 7, 8 and 14). 
#I Percentage is of the total number of AIDS I IDV cases in Australia. 
#2 Rate is the incidence of H1V infection or AIDS diagnosis per one hundred 
thousand current population. 
New South Walos has both the highest number and rate of AIDS and HIV diagnosed 
cases in all of the States and territories in Australia. Victoria is the State with the next 
highest incidence of HIV and AIDS diagnosis. New South Wales and Victoria 
account for 84.1% of the total number of diagnosed cases of IDV infection in 
Australia and 80.4% of the total number of diagnosed AIDS cases (National Centre in 
HIV Epidemiology and Clinical Research. October 1993). 
Although the Australian Capital Territory has only the sixth highest number of 
diagnosed cases ofHIV infection, the rate per 100000 total current population is third 
highest. The same is for the number of diagnosed AIDS cases. The State I Territory 
with the third highest JWmber of diagnosed cases of HIV infection is Queensland. 
Queensland has also tbe third highest number of diagnosed AIDS cases among all the 
States and Territorios of Australia. 
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Figure 1.3: Cumulative number of diagnosis of HIV ·infection in Australia by State I 
Territory to 30 Juue 1993. 
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Figure 1.4: Incidence of diagnosis of HIV infection per 100000 total population in 
Australia by State I Territory to 3 0 June 1993. 
Western Australia accounts for only 3.8% of the total number of diagnosed cases of 
HIV infection in Australia and 4.5% of the total number of diagnosed AIDS cases. 
Although Western Australia accounts for less than 5% of the total number ofHIV and 
AIDS cases, it is the State I Territory with the forth highest number of diagnosed cases 
of infection. Western Australia has an incidence of HIV infection that is only the sixth 
highest among the eight States/ Territories. 
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1.4 HIV and AIDS in Western Australia 
The first AIDS case in Western Australia occurred in 1983 and again this was from 
homosexual contact (AIDS Bureau, 1993) (Health Department of Western Australia, 
1993). The number of new diagnosis of AIDS cases has not been continuously 
increasing as is the case for Australia. There was a decrease in the number of newly 
diagnosed HIV and AIDS cases in 1987 and again in 1988. Figure 1.5 is based upon 
Table 1.4 and shows the changes in the number of newly diagnosed AIDS cases each 
year. 
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Figure 1.5: Number of new and cumulative cases of diagnosis of HIV infection in 
Western Australia by year of diagnosis, 1983 to 21 September 1993. 
By 21 September I 993 there were a total of 788 diagnosed cases of HIV infection of 
which 238 had progressed to AIDS as shown in Table 1.4 (AIDS Bureau, 1993). 
Figure 1.6 shows that of the 238 diagnosed AIDS cases, 155 have died from AIDS. 
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68% of all diagnosed cases of HIV infection are living and have not progressed to 
AIDS and 2% have died from causes other than AIDS. 
Table 1.4: Number of new and cumulative cases of diagnosis of HIV infection and 
AIDS in Western Australia by year of diagnosis, 1983 to 21 September 
1993. 
HIV INFECTION AIDS CASES 
YEAR NEW CUMULATIVE NEW CUMULATIVE 
1983 2 2 2 2 
1984 15 17 4 6 
1985 102 119 35 41 
1986 109 228 39 80 
1987 83 311 38 118 
1988 73 384 19 137 
1989 93 477 26 163 
1990 93 570 28 191 
1991 106 676 25 216 
1992 68 744 17 233 
1993# 44 788 5 238 
(AIDS Bureau 1993, Table 4). 
# Statistics for 1993 are incomplete. 
------~IILMNG HIV (NON AIDS) CASE 
111 LMNG AIDS CASE 
II NON AIDS DEATH 
llAIDS DEATH 
536 (68.0%) 
155 (19.7%) 
Figure 1.6: State of all HIV cases diagnosed in Western Australia, notified from 1983 
to 21 September 1993 _ 
(AIDS Bureau 1993, Table Ia) 
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Table 1.5: Cases of IDV infection in Western Australia by age and sex, notified 
from 1983 to 21 September 1993. 
MALE 
AGE NUMBER OF PERCENTAGE 
CASES 
0-9 5 0.7% 
10-19 17 2.3% 
20-29 291 39.2% 
30-39 256 34.5% 
40-49 126 17.0% 
50-59 36 4.8% 
60+ ll 1.5% 
ALL AGES 742 100% 
(AIDS Bureau 1993, Table 2). 
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Figure 1.7: Cases ofiDV infection in Western Australia by age and sex, notified from 
1983 to 21 September 1993. 
(Table 1.5). 
Approximately 74% of diagnosed IDV infection in Western Australia occurred in 
individuals aged between 20 and 39, shown in Figure 1.7. Of the 46 females 
diagnosed with the IDV virus in Western Australia, 76.1% were aged between 20 and 
39 and 15.2% were aged between 40 and 49. This is similar to the males of which 
73.7% of the 742 diagnosed cases ofiDV infection were between the ages of20 and 
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39, and 17% were between the agel of 40 and 49. These percentages and numbers of 
diagnosed cases of IHV infection in Western Australia by age and sex are shown in 
Table 1.5. 94.2% of all diagnosed cases of IHV infection in Western Australia were 
males. Males aged between 20 and 29, the largest group by sex and age, accounted 
for 36. 9"A. of all diagnosed cases. 
Table 1.6: Number of new diagnosis of lUV infection in Western Australia by 
transmission category and year of diagnosis, 1983 to 21 September 1993. 
CATEGORY 
YEAR HIBI Hllll&ID IVDU !lET. BLOOD PER. UNKNOWN 
1983 2 0 0 0 0 0 0 
1984 8 0 0 0 7 0 0 
1985 83 5 I 4 9 0 0 
1986 87 6 6 3 5 0 2 
1987 65 6 5 5 I I 0 
1988 54 8 3 4 3 0 I 
1989 65 9 9 4 4 0 2 
1990 65 6 6 10 3 0 3 
1991 79 3 8 13 I 0 2 
1992 48 3 6 II 0 0 0 
1993# 32 I 0 7 0 2 2 
TOTAL 588 47 44 61 33 3 12 
(AIDS Bureau 1993, Table 4). 
# Statistics for 1993 are incomplete. 
H/BI: Homosexual or bisexual ~ontact. 
HIBI&ID: Homosexual or bisexual contact and IV drug use. 
IVDU: Intravenous drug user. 
HETERO: Heterosexual contact. 
BLOOD: Contaminated blood products. 
PER: Perinatal transmission. 
The percentage of known modes of transmission of the virus that occurred from 
homosexual/bisexual contact, at approximately 75%, is slightly less than the 
percentage for Australia. Infection from heterosexual contact and IV drug use. 
approximately 8% and 6% respectively, is slightly higher for Western Australia than 
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for Australia (Health Department of Western Australia, 1993) (AIDS Bureau, 1993). 
Figure 1.8 shows the numbers and percentages of the cumulative number of diagnosed 
cases of HIV infection accounted for by various modes of transmission of the virus in 
Western Australia. 
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Figure 1.8: Mode of transmission for lllV infection for all cases in Western Australia 
to 21 September 1993. 
(AIDS Bureau 1993, Table 4). 
# Perinatal transmission or transmission is unknown. 
Table 1.7: Estimated number of living HIV and AIDS cases among heterosexuals in 
Western Australia in 1992 and 1993 # from sexual contact or intravenous 
drug use. 
SEX MODE OF HIV INFECTION AIDS CASE 
TRANSMISSION 1992 1993# 1992 1993# 
MALE IVDU 21 20 3 3 
SEXUAL 10 10 2 1 
FEMALE IVDU 20 23 3 4 
SEXUAL 17 18 3 3 
(Health Department of Western Australia, 1993, Tables 12 and 15). 
(AIDS Bureau, 1993, Tables 1a and 4). 
# 1993 data is only to 21 September 1993 and is therefore incomplete. 
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Figures l. 9, l.l 0 and 1.11 show the number of newly diagnosed cases of HIV 
infection in Western Australia due to the main modes of infection of the lllV virus 
based upon Table 1.6. Homosexual and bisexual contact accounted for the largest 
number of diagnosed infections, but the number of new cases diagnosed each year due 
to this mode of transmission has been decreasing. Heterosexual contact has not 
accounted for a large number of infections, but the number of newly diagnosed cases 
has been increasing as has been the case for transmission through intravenous drug 
use. 
1983 1984 1986 1986 1987 1988 1989 1990 1991 1992 1893 
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Figure 1.9: New and cumulative number of diagnosis of lllV infection through 
homosexual and bisexual contact in Western Australia by year of diagnosis, 
1983 to 21 September 1993. 
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Figure 1.10: New and cumulative number of diagnosis of HIV infection through 
heterosexual contact in Western Australia by year of diagnosis, 1983 to 21 
September 1993. 
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Figure 1.11: New and cumulative number of diagnosis of HIV infection through 
intravenous drug use in Western Australia by year of diagnosis, 1983 to 21 
September 1993. 
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The pattern of spread for Western Austndia can be summarised as follows: 
- The initial cases of HIV and AIDS cccurred in the early 1980's. 
-Homosexual transmission was the main mode of transmission in the early stage of the 
epidemic. 
Transmission from homosexual contact is decreasing while transmission from 
heterosexual contact and from IV drug use is increasing. 
- Transmission from blood products is under control through screening programs. 
- The male to female ratio of HIV infection in Western Australia is approximately 
16: I. 
- Few perinatal cases have occurred. 
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2. Mathematical Models 
2.1 Background to Epidemic Models 
Bernoulli ( 1700-1782) was the first known individual to use an explicit model to 
descnbe an infectious disease, smallpox. His was the first instance where sensitivity 
analysis was applied to a mathematical model when he made comparisons of the life 
expectancy without variolation, with variolation being effective, aod with death from 
variolation (Bailey, 1985). 
DuviUard followed the same lines as Bernoulli, but using the vaccination instead of 
variolations for his work. Farr used empirical curve-fittlng on data to extrapolate 
results. These results were inaccurate, but the theory applied provided the correct 
curve shape for the data (Bailey, 1985). 
Hamer was the first to work on the theory that an epidemic depends upon the number 
of susceptibles at risk and the contact rate between susceptibles and infectious 
individuals. Ross, studying malaria, derived a simple threshold result which stated that 
malaria could be eliminated by reducing the mosquito population instead of eliminating 
the mosquito population altogether. Ross, using differential equations a;!d data 
manipulation, noted that epidemics were probabilistic and followed a Poisson 
distribution (Bailey, 1985). 
Kerrnack and Mckendrick produced the 'Threshold Theorem' which applies to an 
epidemic in a homogeneous population where complete immunity occurs after 
recovery from infuction. The theorem states that there exists a population den~ty 
threshold value which depends upon the transmission and recovery rates of the 
particular disease. The theorem also states that an epidemic would only occur i( at 
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the introduction of an infectious individual into a susceptible population, the density <>f 
the susceptibles was above the particular critical threshold level. The effect of the 
epidemic will be to reduce the density of the susceptibles, through infection, to a level 
as far below the critical threshold value as initially it was above it. The critical 
threshold value is the relative removal rate of the disease. The relative rernovaJ rate is 
given by the total removal rate divided by the total infection rate of the disease (Bailey, 
1975, 1985). 
Mckendrick was the first to use a stochastic model in continuous time with various 
different classes for susceptibles, infectives, those who die from the disease and those 
who recover and are immune to the disease. Work continued on the probabilistic 
nature of epidemics as well as deterministic and stochastic theory and application. 
Both of these processes were used to account for epidemics that were periodic due to 
temporary immunity (Bailey, 1985). 
2.2 Simple Epidemic Models 
The following section on epidemic models of direct contact transmission only was 
based upon Bailey (1975) and James & Steele (1990). One should first consider a 
simple model where individuals are either susceptible or infective and the population is 
a constant size. All infectives are equally infective and are not removed and do not 
recover from infection. All susceptibles are equally suscepttble and the population 
mixes homogeneously. The number of susceptibles at time t is represented by x(l) 
and the number ofinfectives at timet is represented by y(l). 
At the start of the epidemic, there are N susceptibles and I infective. The number of 
new infectives is dependent upon the number of susceptibles and the number of 
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infectives. The transmission rate p, is a combination of the proportion ofsusceptibles 
coming into contact with an infective and the proportion of these susceptibles which 
become infected through this contact. The number of new infectives, o/ during the 
time interval [1 ,I+ <i] is : 
o/ = {Jx(l)y(l)<i'. 
As the limit <i'-> 0, the number ofinf<'Ctives at timet is given by: 
dy = {Jxy 
dl 
or dy ={Jy(N-y+I)asx+y=N+I. 
dl 
The last equation can be rewritten as : 
! dy 
f.y(N- y+ I) 
and integrated to give : 
' J /Jdl 
0 
N+l 
y(t) = I +ne·<••lll' ' 
known as the logistic equation. A plot of the rate at which new infections occur is 
referred to as an epidemic curve, Figure 2.1. This curve has a maximum when : 
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and 
/11= ln(N) 
N+l 
I 
r=y="2(N+I). 
The simple model is described by Figure 2.2, a flow diagram of individuals in the 
population and by equations 2.1 below. 
dr 
-=-{Jxy 
dt 
dy ={Jxy 
dt 
(2.1) 
Healthy and 
Susceptible 
Infected and 
lnfedlous 
Figure 2,2: Flow diagram of a closed population of only infectives and susceptibles 
with no recovery from infection. 
The next step in the model is to incorporate recovery from infection. Those 
individuals which recover are assumed to return to being susceptible. The model for a 
closed population of only susceptibles and infectives with recovery from infection is 
given below and a flow diagram of individuals in the population is given by Figure 2.3. 
dr 
-=-flxy+yy 
dt 
dy =flxy- yy 
dt 
Heollhy and 
Susceptible 
l 
(2.2) 
Infected and 
Infectious 
j 
Fjure 2.3: Flow diagram of a closed population of only infectives and susceptibles 
with recovecy from infection. 
i 
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The recovery rate is given by y and the number of individuals which recover is 
proportional to the total number of infectives. Again the size of the susceptibles is N 
and I infective is introduced at the start ofthe epidemic. The disease spreads tllrough 
the population and the number of infectives reaches an equilibrium of N + 1-;. and 
the number of susceptibles reaches the equilibrium point of ; only if the number of 
susceptrbles was greater than ; when the first infective was introduced into the 
population. If the number of susceptibles was not greater than the relative removal 
rate,; for the particular disease, then the disease would not spread through the 
population. As the number of infectives and susceptibles reaches a stable equilibrium, 
the disease is referred to as endemic. 
Rather than the infectives recovering and returning to the susceptible population to be 
re-infected, the following model allows for infectives to be inunune after having 
recovered. The model for a closed population of only susceptibles and infectives with 
recovery and inmnmity from infection is given below and where the number of 
individuals which are immune at time I is given by z(t). 
dx 
dt = -fJxy 
4Y = fJxy- ay (2.3) 
dt 
dz 
-=ay dl 
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Figure 2.4: Flow diagram of a closed population were infectives are ~solated and 
recover to be immune from further infection. 
The removal rate is given by a and the number of infectives being immune is still 
proportional to the tota1 number of infectives. At the start of the epid~mic there are 
again N susceptibles and 1 infective. The epidemic will only occur if the number of 
susceptibles at the start of the epidemic is greater tban the relative removal rate, ; of 
the particular disease. The following AIDS models are based upon equations 2.3 with 
z(l) being infectives which have progressed to AIDS and are considered no longer 
infectious. 
2.3 Early HIV/AIDS Models 
One of the earliest models described below, was developed by Anderson (1988a) and 
is a very simple homogeneous mixing model describing the epidemic in a closed 
population. This model does not allow migration or recruitment into the population 
and removal is only by death from AIDS. In a homogenoous model individuals choose 
on average the same number of partners. The rate of change in the number of 
susceptibles dX(t) I dt is given by the number of susceptibles infected. This is 
determined by the proportion oftbe population infected YIN, the average number of 
new sexual partners of an individual c , the probability of infection from a single sexual 
contact P, and tbe number of susceptibles in the population. The term 'single sexual 
23 
contact' is often used and generally refers to a single sexual partnership rather :han a 
single act of sexual intercourse. If the term used refers to a single sexual act then 
another parameter is required which represents the average frequency of sexuai 
intercourse. Studies have shown that the frequency of sexual contact has little effect 
on the probability of transmission ofthe HIV virus (Anderson, 198Sb), (Anderson, and 
Medley, 1988). 
The rate of change in the number ofinfectives, dY(t)l dt is determined by the number 
of susceptibles infected minus the number of infectives which have progressed to 
AIDS. The number of infectives progressing to AIDS is determined by the removal 
rate v, where II v is the incubation period for the HIV virus. The rate of change in 
the population dN(t)l dt is determined by the deaths from AIDS, given by a, the 
mortality rate and the number of AIDS cases, A. The rate of change in the number of 
AIDS cases, dA(t)l dt is determined by the number of new AIDS cases from 
infectives progressing to AIDS minus deaths from AIDS. The Anderson ( 1988a) 
model is given by: 
where 
dX(t) I dt ~ -fJcXY IN 
dY(t) I dt ~ flcXY IN- vY 
dA(t)l dt ~ vY- a4 
dN(t)l dt ~ -a4 
N(l); X( I)+ Y(t)+ A(t) 
(2.4) 
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SUSCEPTIBLE 
(HIV NEGAllVE) 
INFECTIVE AIDS CASE 
(HIV POSITIVE) (NOT INFECTIVE) 
(AIDS DEAlll) 
~ of the Anderson ( Model. 
A later model was developed by Isham (1988) and is again a closed population, but 
this model is a heterogonous model as it allows for differences in choices of new 
sexual partners for males, c. and females, c1 . This model also allows for differences in 
the probability of infection from sexual contact, fJ for males and females and different 
incubation periods for males, 1/ v. and females, 1/ v1 . The probability of a male 
being infected by a female is given by p1 and the probability of a female being infected 
by a male is given by fl •. The equations are very similar to the previous model except 
for the susceptibles and infectives being divided into male, x. and r. respectively, 
and female, X1 and Y1 respectively, groups. The Isbam (1988) model is given by: 
SUSCEPTIBLE 
(HIV NEGAllVE) 
INFECTIVE AIDS CASE 
(HIV POSillVE) (NOT INFECllVE) 
Fil!!tt 1.6: Flow diagram of the Isham ( 1988) Model. 
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df/1) 
dt 
dA.,(I) 
v,.Y ... dt 
dA,(t) 
dt v,Y, 
N.(l) = X.(I)+Y.(I)+A.(I) 
N1 (t) = X 1 (t)+Y1 (t)+A1 (t) 
N(l)= N.(l)+ N1 (t) 
(2.5) 
This model is a heterogenous model and therefore allows for differences between 
males and females in partner choices and probability of transmission. The model does 
not, however, allow for migration and recruitment into the population, something 
whioh occurs in reality. The above Isham model only deals with transmission among 
the heterose>rual population through sexual contact. The model required needs to 
incorporate transmission of the HIV virus through intravenous drug use. 
2.4 Proposed Model 
The proposed model is based on a model developed by Comiskey (1992) where the 
virus is transmitted through heterosexual contact and IV drug use. This is not a closed 
population, and therefore includes migration and recruitment to and from the 
population. Recruitment into the population is through starting drugs or sel(lJal 
activity. Migration from the population can be from death, either from AIDS or from 
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other causes, or from no longer using drugs or no longer being sexually active. The 
population consists of heterosext~als in Western Australia who either use intravenous 
drugs or are sexually active. 
The population is divided into three classes, susceptible, X(l), infective, f(l), and 
AIDS sufferers, A(l). These classes are further divided into four groups, (I) male IV 
drug users, (2) female IV drug usern, (3) male non-IV drug users and (4) female non-
IV drug users. The following is a list of aU the variables and parameters used in the 
model. 
X,(l) :Number ofsusceptibles at time 1 from group i. 
Y,(l) :Number ofinfectives at time 1 from group i. 
A,(l) : Number of AIDS cases at time I from group i. 
P,(l) : Total population of group i at time I. 
p10 : Probability of transmission of the mv virus through sexual contact from a female 
infective to a male SIL<ceptible. 
Po~ : Probability of transmission of the IllY vi'11s through sexual contact from a male 
infective to a female susceptible. 
' p: Probability of transmission of the lllV virus through the sharing of needles. 
A1: Recruitment rate into group i. 
p,: Migration rate from group i. 
q,: Average number of needle sharing 'partners' that an individual from group i has in a 
year (i = 1,2). 
c,: Average number of sexual partners an individual from group i chooses from group 
j in a year. 
a: Rate of progression of the IllY virus (Mean incubation period is II a). 
8: Death rate from AIDS. 
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The rate of change in the number of susceptible male IV drug users dX, (I) I dJ is 
detennined by the recruitment rate into the group A,, minus susceptibles being 
infected by needle sharing or from sexual contact and migration of individuals from 
this group p,. The rate of change in the number of susceptible female IV drug users 
dX2(1)1 dl is determined by the recruitment rate into the group A,, infuction from 
needle sharing and sexual contact and migration from the group p,. 
dX,(I) =A -" p' X (I)[ Y, (I)+ Y,(l) ]-c " X (I) Y,(l) -c a X (t) Y,(l) 
dt ' . ., ' P,(I)+P,(I) •ll'fo ' P,(l) ""fo ' P4 (1) 
-p,X,(I) 
(2.6.1) 
dX,(I)=A -" p'X(IJY,(I)+f,(l)]-c a X(I)Y,(I)_c p X(l)f,(l) 
dl ' . ., 2 LP.(I)+P,(I) '"'"" 2 P,(l) " "' 2 P,(l) 
-p,X,(I) 
(2.6.2) 
A 
Infection from sharing needles is given by p, the probability of infection from a single 
needle sharing act, q1, the average number of times an individual from group j shares 
a needle, the number of susceptibles in group j, X1(1) and the proportion of drug 
users which are infected, {Y, (I)+ Y,(l)} I {P,(I) + P,(t)}. 
The rate of change in the number of susceptible male non-IV drug users dX3 (1)1 dl is 
detennined by the recruitment rate into the group A,, infection from sexual contact 
and the migration rate from the group p 3 • The rate of change in the number of 
susceptible female non-IV drug users dX4 (1)1 dJ is determined by the recruitmont rate 
A,, infection from sexual contact and migration from the group p,. 
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Infection from sexual contact is divided into contact with IV drug users or non IV 
drug users. Only a proportion of non IV drug users will mix with IV drug users and 
this proportion represented by p1, for group j, where j is 3 or 4, male and female 
non-IV drug users respectively. The mean number of sexual partners an individual 
from group i chooses from group j is represented by c;1 . For example c14 is the 
mean number offemale non-IVDU sexual partners which a male intravenous drug user 
has in a year. The probability of infection of a male susceptible from sexual contact 
with a female infective partner is given by p"' and the probability of a female 
susceptible being infeeted by a male infective partner through a sexual contact is given 
by p,.. The proposed model is given by: 
dX1(I)=A -npX(I)[l;(I)+Y2(I)]-c n X(t/'(t)_c p X(t)f.(l) 
dt I "'I I P,(I)+P,(I) IU'fo I P,(l) I< fo I P,(l) 
-PtX1(1) 
(2.6.1) 
dX2(I) A - px (t,[l;(t)+Y,(f)]-c /3, X(l)l;(t) -c p X (t/'(l) 
dt 2 '12 2 'l_P,(I)+P,(I) 21 "' 2 P,(l) ""' 2 P,(t) 
-p,X2(t) 
(2.6.2) 
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(2.6.3) 
(2.6.4) 
dl';(t)= p'x(J!;(t)+Y,(t)]+c p X(t)Y,(t)+c p X(t)Y,(t) 
d/ 'II I 'L ~(/)+P,(I) 12 fo< I P,(l) 14 fm I P.,(/) 
-(a+p1)Y,(t) 
(2.6.5) 
df2(/)='7 p'X(t)[l;(l)+f2(t)]+c" X(l)l;(t)+c a X(t/,(1) 
dt 2 2 ~(I)+P,(I) 21Poif 2 ~(/) 2>1'.; 2 P,(t) 
-(a+p2)Y,(I) 
(2.6.6) 
dY,(t) = n c,2P~X,(t) Y,(l) +c "~X,(t) l;(l) -(a+ n 3)Y.,(I) (2.6.7) dl ,.., ,... P,(l) 341',." 1',(1) r 
dY,(I) _ l;(l) Y,(l) 
dt -p4c41P.;X4 (1) ~(t) +c4J3.;X4 (1) P,(t) -(a+p4)J;(t) (2.6.8) 
dA,(t) = af;(l)-(8+ p)A,(t) (2.6.9) 
dt 
P,(l) = x;(t)+ Y,(I)+A,(t) (2.6.10) 
for i=l,2,3,4 
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Fi!!Urt 2.7: Flow diagram of the proposed model. 
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3. Model Parameters 
3.1 Population Sizes 
The differential equations for the model of the spread of the mv virus requires 
estimates of the population sizes of each risk group. The total number of males and 
females in Western Australia between the ages of 15 and 49, has been increasing each 
year, from 1976 to 1992, except for 1991 when there was a decrease of about 8000 
people from the previous year, as shown in Figure 3 .I which is based upon estimated 
resident population figures (Austrafian Bureau of Statistics, 1982, 1987 and 1993). 
The increase in the size of the population needs to be included in the model. 
500000 ---MALE 
4&0000 -+-FEMALE 
400000 
NUMBER = t:a= OF 28~Dt------------------------------------------
~~ALS200H0f------------------------------------------
16~0+------------------------------------------
100000 +------------------ -----------------------
~ooot------------------------------------------
0~+-~~~~-+~~--~~+-~~~-+~ 
nnnn~~~~M~$U~n~~~ 
YEAR 
Figure 3.1: Estimated resident population of aU people aged 15 to 49 years in Western 
Australia by sex for each year from 1976 to 1992 (preliminary). 
*Each value was estimated at 30 June of ea,ch year. 
The age range of 15 to 49 years is based upon Comiskey (1992) and Rollins (1989). 
These state that the mean age for first sexual intercourse for females is approximately 
15 years. Most Australian studies have been targeted at the younger population, 
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which is why the duration of being sexually active for heterosexuals for 35 years is 
based upon Comiskr.y (1992). 
Loxley, eta!, 1991, page 363, state that" ... there may be as many as 80000 lVUDs in 
Australia, ... ' and" In one study it was found that 1 to 3% of people aged 16-24 bad 
injected therno;elves with drugs within the last 12 months ... ". The 1-3% of 16-24 year 
olds gives a Western Australian estimate for the number ofN drug users in 1985 to be 
between 2183 and 6548 people and in 1990 to be between 23 77 and 7131 people. 
The male to female ratio of63.3 : 36.7 of respondents in Perth to the ANAIDUS study 
is used for the ratio of male to female IVDUs in Western Australia. 
The population of non-IVDUs is the total population aged 15-49 minus those using 
intravenous drugs. The population estimates for male and female IVDUs and non-
IVDUs is given in Table 3.1. These estimates are for the total number of males and 
females including bisexuals and homosexuals. 
Table 3.1: Estimated number of all male and female IVDUs and non-IVDUs in 
Western Australia in 1985 and 1992. 
% PEOPLE 16-24 YEARS MALE FEMALE MALE FEMALE 
USINGIVDs !VDU IVDU NON-!VDU NON-IVDU 
1985 (1%) 1382 801 388536 371213 
1985 (2%) 2764 1602 387154 370412 
1985 _!3%) 4146 2402 385772 369612 
1992 (1%) 1505 872 455920 443004 
1992 (2%) 3009 1745 454416 442131 
1992 (3%) 4514 2617 452911 441259 
The sexual orientation of the respondents to the ANAIDUS study is given in Table 
3.2, which is based on t..b1e 49 on page 62, Australiau National AIDS and Injecting 
Drug Use Study, 1992 and table 22 on page 68, Loxley, et al, 1992. 
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ORIENTATION OVER MALE FEMALE 
HETEROSEXUAL 82 (89.1%) 40 (74.1%) 
BISEXUAL 6 (6.5%) 13 (24.1%) 
I 
92 54 
MALE FEMALE 
81 (91.0%) 47 (85.5%) 
1(1.1%) 7 (12. 7%) 
7 
The percentage of heterosexual females appears too low compared to the percentage 
of heterosexual males in the same study. This low percentage could be due to a bias in 
the survey sample. The sexual orientation from the last 5 years wiU be used instead of 
current sexual orientation as it accounts for a reasonable length of time. Table 3.3 
presents the population sizes for male and female IVDUs and non-IVDUs based upon 
the sexual orientation of the Perth respondents to the ANAIDUS survey. The 
population sizes for 1985 correspond to the initial populations of the risk groups at the 
start of the epidemic, P,(O) fori= I to 4. 
Table 3.3: Population sizes for heterosexual male and fema1e IVDUs and non-IVDUs 
in 1985. 
%OF PEOPLE 16-24 MALE FEMALE MALE FEMALE 
YEARS USING IVDs !VDU IVDU NON-!VDU NON·IVDU 
P,(O) P,(O) P,(O) P,(O) 
(I%) 1231 594 346186 275069 
(2%) 2463 1187 344954 274475 
(3%) 3694 1780 343723 273882 
The annual increase in the size of the male heterosexual population from 1985 to 1992 
is 8593 males per year and the annual increase in the size of the female population 
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from 1985 to 1992 is 7607 females per year when it is assumed that 2% of people 
aged 16 to 24 take up intravenous drugs. The annual increase for each population 
group is shown in Table 3.4. 
Table 3.4: Annual increase in population sizes of heterosexual male and female 
IVDUs and non-IVDUs from 1985 to 1992. 
%OF PEOPLE 16-24 MALE FEMALE MALE FEMALE 
YEARS USING lVDs !VDU !VDU NON-!VDU NON-!VDU 
(1%) 16 7 8577 7600 
(2%) 31 15 8562 7592 
I (3%J 47 23 8546 7584 
3.2 Recruitment and Migration Rates 
Assuming the duration of being sexually active is 3 5 years for both male and female 
heterosexual non-IVDUs, age 15 to 49, the migration rate for both groups is 1/35 or 
0.02857 per year. The migration rate for male and female IVDUs is based upon the 
reciprocal of the mean duration of their drug using habit as estimated by Comiskey 
(1992). The respondents to the ANAIDUS study were not asked how long they were 
using drugs, so the estimate is based upon the average age of the respondents at the 
time of the survey minus the average age with which they started taking intravenous 
drugs. The duration of the drug taking habit is used for IVDUs rather than the 
duration of being sexually active, as the probability of transmission of the HIV virus 
from sharing needles is greater than that for sexual contact among heterosexuals. 
The mean age of first injecting drugs for the total Perth sample was 19.0 years with a 
95% confidence interval of 18.4- 19.6. The mean age of all the Perth respondents at 
the time of the survey was 28.6 years with a confidence interval 27.7 - 29.5 
(Australian Natioual AIDS and I.Yecting Drug Use Study, !992) (Loxley, et at, 1992). 
At the time of the survey, some respondents were no longer taking drugs. The mean 
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age for respondents giving up drugs is therefore assumed to be 28.6 years and the 
duration of the drug taking habit for all respondents is estiltlliled to be 9.6 years. The 
migration rate per year is therefore 1/9.6 or 0.10417 for both male and female IVDUs. 
FEMALEIVDU 
MALE NON-IVDU 
0.10417 
0.10417 
0.02857 
RATE 
If it assumed that without the virus the population sizes of male and remale IVDUs 
and non-IVDUs remains constant, then the recruitment rate equals the yearly 
migratlon rate. As the population sizes are not constant, the recruitment rate per year 
for each group is estimated using the migration rate multiplied by the initial population 
size in 1985 plus the annual increase shown in Table 3.4 plus the migration rate 
multiplied by the annual incr.,.se. 
%OF PEOPLE 16-24 MALE MALE FEMALE 
YEARS USING IVU. ~~~~----~~£_-----+~~~~~~~~~~ 
1% 
2% 
15676 
15651 
15626 
In the case of male non-IVDUs aged 16 to 49 years, the population in 1985, the start 
of the epidemic, was 344954 individuals, assuming that 2% of people 16 to 24 years 
take up IV drugs. In 1986 this is reduced by 9856 through individuals migrating out 
of the population. In order for the model to be representative of the situation in 
Western Australia, the male non-IVDU population needs to have an increase in the 
number of individuals each year of about 8562, the annual increase. As migration will 
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occur in 1987 from those which were recruited through the annual increase, this 
migration is also added to the total recruitment rate. The recruitment rate for the 
male non-IVDU group is therefore 8562 (annual increase) plus 9856 (initial migration) 
plus 244 (migration of the annual increase). Table 3.6 represents the recruitment rate 
per year for each risk group. 
3.3 Cboice of Partners 
The heterosexual female respondents of the ANAIDUS study had on average 8.3 
male partners in a year with a 95% confidence interval of 4.7- 11.8 partners. Of the 
regular partners in a year, 84.4% were intravenous drug users (Australian National 
AIDS and Injecting Drug Use Study, 1992). This percentage will be used for aU 
partners, therefore of the 8.3 partners in a year, 7.0052 are IVDUs and 1.2948 are 
non-IVDUs. 
The heterosexual male respondents of the ANAIDUS study had on average 4.4 female 
partners in a year. Of the regular partners ofthe male IVDU respondents, 62.2% were 
intravenous drug users (Australian National AIDS and Injecting Drug Use Study, 
1992). This percentage is used for all partners, therefore of the 4.4 partners in a year, 
2.7368 are IVDUs and 1.6632 are non-IVDUs. Table 3.7 represents the partner 
choices for a year for heterosexual IVDUs in Perth and Sydney combined. 
Table 3.7: Partner choices for heterosexual male and female IVDUs for a year in 
Perth and Svdnev. 
NUMBER OF PARTNERS 
IVDU MALE FEMALE MALE FEMALE TOTAL 
GROUP IVDU IVDU NON-IVDU NON-IVDU 
MALE 
-
2.7368 
-
1.6632 4.4 
FEMALE 7.0052 - 1.2948 
-
8.3 
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The female respondents ofthe Perth study bad on avernge 7.8 partners in a year. The 
respondents to the Penh study were not just heterosexuals, they also included 
bisexuals and homosexuals and the sexuality of the respondents was not taken into 
account in this question. Of the regular partners in a year, 92.7% were intravenous 
drug users (Marsh, et al, 1991). This percentage is used for all partners, therefore of 
the 7.8 partners in a year, 7.2306 are IVDUs and 0.5694 are non-IVDUs. 
The male respondents of the Penh study had on average 4.6 partners in a year. Of the 
regular partners of the male IVDU respondents, 64.5% were intravenous drug users 
(Marsh, et al, 1991). This percentage is used for all partners, therefore of the 4.6 
partners in a year, 2.967 are IVDUs and 1.633 are non-IVDUs. Table 3.8 represents 
the partner choices for a year for all male and female IVDUs in Perth which are not 
prostitutes. 
Table 3,1: Partner choices for all male and female IVDUs for a year in Perth 
(excluding prostitutes). 
IVDU NUMBER OF PARTNERS 
GROUP IVDU NON-IVDU TOTAL 
i =I i=2 i=3 i=4 
MALE Cti - 2.967 - 1.633 4.6 
FEMALE c,; 7.2306 - 0.5694 - 7.8 
Tables 3. 7 and 3.8 show that the total number of partners in a year for IVDU 
heterosexuals in Penh and Sydney combined is similar to the total number of partners 
in a year for all intravenous drug users in Perth. The number of partners in a year for 
heterosexual IVDUs in Perth should be lower than that for the total in Table 3.8, as 
homosexuals and bisexuals tend to have a hijsher number of partners in a year than 
heterosexuals (Australian National AIDS and Injecting Drug Use Study, 1991, 1992). 
As Table 3.8 incorporates the total number of partners in a year for Perth IVDUs and 
the percentage of regular partners being IVDU for both male and female respondents, 
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these partner choices will be used in the model. The percentage of regular partners 
being IVDUs does not depend upon the sexual orientation of the respondent, but is 
greater for female respondents than for male respondents. 
Table 3.9: Proportion of the sexually active population that are intravenous drug 
users. 
%OF PEOPLE 16-24 MALE FEMALE 
YEARS USING IVDs IVDUs IVDUs 
1985 (I%) 0.003543 0.002155 
1985 (2%) 0.007089 0.004306 
1985 (3%) 0.010633 0.006457 
1992 (I%) 0.003290 0.001964 
1992 (2%) 0.006578 0.003931 
1992 (3%l 0.009868 0.005895 
PROI'ORTION TO BE USED (I%) 0.003 0.002 
PROPORTION TO BE USED (2%) 0.007 0.004 
PROPORTION TO BE USED iJ% l 0.010 0.006 
Table 3.10: Partner choices for male and female non-IVDUs for a year. 
NUMBER OF PARTNERS 
NON-IVDU MALE FEMALE MALE FEMALE TOTAL 
GROUP IVDU IVDU NON-IVDU NON-IVDU 
i =I i=2 i=3 1=4 
(*I) MALE CJj - 0.0138 - 4.5862 4.6 
FEMALE c,; 0.0136 . 7.7844 
-
7.8 
(*2)MALE c3; . 0.0322 - 4.5678 4.6 
FEMALE c,; 0.0312 - 7.7688 . 7.8 
(*3lMALE CJj - 0.0460 - 4.554 4.6 
FEMALE c,; 0.0468 
-
7.7532 . 7.8 
(*1) 1% of people aged 16 to 24 years taking up intravenous drugs. 
(*2) 2% of people aged 16 to 24 years taking up intravenous drugs. 
(*3) 3% of neoole aaed 16 to 24 years takiog up intravenous drugs. 
Since the ANAIDUS study was only targeting drug users, the number of partners 
which a non-IVDU has in a year is assumed to be equal to that of the IVDUs. A 
heterosexual feml>le is thorefore assumed to have an average of 7.8 partners in a year 
and a heterosexual male is assumed to have an average of 4.6 partners in a year based 
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upon Table 3.8. The proportion of IVDUs in the sexually active population of people 
aged 15 to 49 years is used as the proportion of partners ofnon-IVDUs U600ii are 
intravenous drug users. Table 3.9 represents the proportion of IVDUs in the 
population for males and fen;ales and Table 3.10 represents the partner choices for 
male and fumale non-IVDUs for tho year based upon the proportions in Table 3.9. 
3.4 Other Parameters 
Only a proportion of non~IVDUs will have contact with intravenous drug users and 
this has been incorporated into the model using the estimated number of partners of 
the respondents to the ANAIDUS survey in Perth. The 82 heterosexual male 
respondents had contact with an estimated total of 377 females of which 35.5% or 
134 were non-IVDUs (Tables 3.2 and 3.8). The 40 heterosexual female respondents 
to the ANAIDUS survey in Perth had contact with an estimated total of 312 males 
within the year of which 7.3% or 23 were non-IVDUs (Tables 3.2 and 3.8.). The 
minimum proportion of non-IVDUs in contact with intravenous drug users is given in 
Table 3 .11. The proportion for 1992 is used rather than that for 1985 as it is the most 
recent proporti(,, ~stimate and it is closer to the time of the survey being conducted. 
Table 3.11: Minimum proportion ofnon-IVDUs in contact with IVDUs. 
MALE FEMALE 
YEAR NON-IVDUs NON-IVDUs 
p, p. 
1985 0.00006 0.00037 
1992 0.00005 0.00030 
PARAMETER USED 0.00005 0.00030 
The Perth respondents to the ANAIDUS study shared needles on average with 0.8 
people during 6 months. It is t!1erefore assumed that they share with 1.6 people within 
a year (Australian National AIDS and Injecting Drug Use Study, 1992). Table 1.12 
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represents the number of people IVDUs share needles with in a year and the 95% 
confidence intervals for the parameter. 
95% CONFIDENCE 
1.2-2.0 
Transmission of the lllV virus through sexual contact is taken from published 
estimates (Andem.>n, and May, 1988), (Dietz, 1988). The probability of transmission 
of the mv virus through sexual contact from a female infective to a male susceptible 
has been estimated to he 0.1 and the transmission of the virus from a male infective to 
a female susceptible is estimated to be 0.2. 
The probability of transmission through sharing of nee<Ues is known to be higher than 
that for sexual contact. The probability is therefore taken to be 0.2, the highest 
probability of transmission through heteroseXUlll contact. Transmission rates are 
shown in Table 3. 13. 
P.r : SEXUAL CONTACT (MALE TO FEMALE) 0.2 
Pr.: SEXUALCONTACT(FEMALE TO MALE) 0.1 
0.2 
The respondents to the AN AID US survey were using condoms some of the time. This 
can be taken into account either through the transmission parameters or through the 
number of partners. Table 3.14 is based upon tables 52 and 53 on page 66 of the 
third report of the Australian National AIDS and Injecting Drug Use Study, 1992. 
Table 3.15 represents the sexual transmission rate of infection if condom use is 
considered, using the mean for the whole sample surveyed given in Table 3.14. The 
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transmission rate for sexual contact from male to female is normally estimated to be 
0.2, Table 3.13. If condom use for all partners is considered, the sexual transmission 
rate from male infective to female susceptible is estimated to be 0.2 multiplied by 
0.645, the percentage of the time condoms are not used giving an estimated 
transmission rate of 0.129. Th,, same applies for transmission from female infective to 
male susceptible and for condom use for regular partners. 
MAJil 
FEMALE 
-3.15: Sexual transmission rates considering current condom use. 
TRANSMISSION ALLPARTNERS REGULARPARTNERS 
Jlmr :MALE TO FEMALE 0.1290 0.1670 
/1, :FEMALE TO MALE 0.0645 0.0835 
The death rate from AIDS, 8, has been estimated to be 1.000, the reciprocal of the 
survival period of I year (Blythe, and Anderson, !988),(May, and Anderson, 1987). 
The incubation period fur tbe mv virus has been estimated to be 8 years (Anderson, 
et al, 1986),(Medley, et al, 1987) and the removal rate due to the progression of the 
dbease, a, is tberefure 1/8 or 0.125. 
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4. Model Results 
4.1 Simulations 
The computer simulations on the program for the model of the spread of the HIV virus 
among heterosexuals in Western Australia, in Appendix I were performed using the 
NAG FORTRAN Library, D02EBF to solve the differential equation.,. The D02EBF 
Library uses the variable order, variable step Gear Method, Appendix 3. 
Simulations were conducted using 1%, 2% and 3% of people aged 16 to 24 taking up 
intravenous drugs. The initial year of the simulation has been taken to be 1985, the 
first year in which an individual was diagnosed as being infected through IV drug use 
in Western Australia. In 1985 the first case of infection from heterosexual contact was 
also diagnosed. The simulations were set to forecast the total number of mv and 
AIDS cases alive each year to the year 2025. 
The probability of transmission through sexual contact was varied due to the 
difference in condom use between regular partners and all partners and to investigate 
the effect ofthe differences on the epidemic. The average number of people which an 
IV drug using individual had shared a needle with during a year was reduced from I. 6 
to I to also investigate its effect on the epidemic. Reducing the needle sharing 
'partners' from 1.6 to I was decided by choosing a number which was less than the 
lower bound of the 95% confidence interva1 for the mean number of partners in a year 
and above half of the mean number of partners in a year. 
Some simulations were conducted where behaviour modifications were introduced in 
1994. These were then compared to the original simulation for each model to 
investigate whether it would be worthwhile proposing such intervention policies be 
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introduced for these changes in behaviour. These comparisons will also aid in deciding 
on what type of behaviour, needle sharing or condom usage, to target in these 
intervention policies. 
The results are divided into three parts for each 'model'. The first 'model', model A, is 
based upon I infected male IVDU being introduced into the population in 1985. This 
was to determine the size of the spread of the mv virus from intravenous drug users 
to non-IVDUs. The choice of 1 male IVDU instead of 1 female IVDU was oo.- to the 
actual reported situation in 1985 where the only case of lnfection occming cln.-ough 
intravenous drugs was in a male. 
The second 'model', model B, is based upon I infected male non-IVDU being 
introduced into the population in 1985. This was to determine the spread of the HlV 
virus from non-IVDUs to IVDUs. As there were 3 reported cases of HIV infection 
through sexual contact among males and only 1 reported case among females, the 
introduction of 1 infected male non-IVDU into the population model is the most 
appropriate choice. 
Model C, the third 'model', is baiied upon a total of 5 infected people being introduced 
into the population in 1985. Of the infected individuals, 1 is a male IVDU, I is a 
female non-IVDU and the rest are male non-IVDUs. These were the actual reported 
cases of infection through heterosexual contact and intravenous drug use in 1985. 
The results !rpm these three models have been displayed as graphs of the number of 
living HlV cases each year from 1985 to 2025 and are found in Appendix 4. Tables 
A4.1 and A4.2 at tho start of Appendix 4 provide the legend used fur all of the figures. 
All of the figures have been constructed using information based only upon 1% of 
people aged between 16 and 24 years using intravenous drugs. These figures provide 
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a comparison of different results given various simulations and should not be used for 
prediction purposes. 
4.2 Results for Model A 
The results for model A, when I infected male IVDU is introduced into the population 
in 1985 are in Tables 4.1 to 4.4 and are the estimated number of living HIV and AIDS 
cases for male and female IVDUs and non-IVDUs in the years 1992 and 2000 when 
1%, 2% and 3% of people aged 16 to 24 take up drugs respectively. The Figures 
A4.1 to A4.15 in Appendix 4 are the results of simulations performed on model A. 
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Figure 4.1: Number of living HIV+ male and female IVDUs and non-IVDUs each 
year from 1985 to 2010 based upon Table 4.1 (I% of people aged 16 to 24 
taking up IVDUs). 
Table 4.1 shows that when condoms were used 16.5% of the time and intravenous 
drug users shared needles on average with 1.6 people in a year, an infected male 
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IVDU will start an epidemic which will cause 45 to 47 male IVDUs, and 40 to 42 
female IVDUs to be infected with the IllY virus, but not have AIDS by 1992. In 
addition, 3 male IVDUs and 3 female IVDUs will be not only infected with the IllY 
virus, but they will have progressed to AIDS in 1992. No cases of IllY infection 
among non-IVDUs will have resulted in 1992 from this initial infection of a male 
IVDU. 
From the initial infection of I male IVDU, between 650 and 1718 male IVDUs 
(depending upon the IVDU population size) will be living with the IllY virus in 2000. 
The number of AIDS cases for the same year is between 69 and 163 living cases 
among male IVDUs. Among female IVDUs, the number of living IllY cases is 
between 380 and 1134, and the number of living AIDS cases is between 42 and 116. 
Infection among non-IVDUs has occurred at this stage with 3 to 4 males being 
infected and living with the mv virus and 5 to 6 females being infected and also 
living. No AIDS cases have occurred among non-IVDU heterosexuals in the year 
2000 when I infected male IVDU was introduced into the population in 1985. 
Table 4,1: Number of AIDS and IllY cases in 1992 and 2000 when condoms have 
been used 16.5% of the time and IVDUs share needles on average with 
1.6 people in a year (Original Model A). 
%OF PEOPLE 16-24 Yt(t) Y2(t) Y3(t) Y4(t) At(t) A2(t) A3(t) A4(t) 
YEARS USING lVDs 
1992 1% 45 40 0 0 3 3 0 0 
2% 46 41 0 0 3 3 0 0 
3% 47 42 0 0 3 3 0 0 
2000 1% 650 380 3 5 69 42 0 0 
2% 1223 768 4 6 122 81 0 0 
3% 1718 1134 4 6 163 116 0 0 
In 1992 there is little difference in the number of infected male and female IVDUs and 
non-IVDUs between the different estimates of the size of the drug using population. 
In 2000, the model shows that although there was little difference in the number of 
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infection between the different population sizes of IVDUs in 1992, a difterence does 
exist. The higher the size of the intravenous drug using population, the larger the 
number of individuals infected in both the IVDU group and the non-IVDU group. 
This is due to the larger pool of susceptibles at the start of the epidemic of the 
intravenous drug users. 
Figure 4.1 shows that by about the year 2000, both of the IVDU groups have reached 
their peak in the number of living IDV cases. The number of living IDV cases among 
non-IVDU heterosexuals, while low in the year 2000, increases dramatically once the 
epidemic has entered the population, while the number of living IDV positive IVDUs 
appears to be decreasing to a stable level. 
Table 4.2 shows that in 1992 when condoms are used 16.5% of the time and IVDUs 
share needles on average with I person in a year, the number of living IDV cases is 19 
to 20 for male IVDUs and 18 to 19 for female IVDUs. Although the average number 
of people which an IVDU shares a needle with is reduced by less than 50o/~ the 
number of living IDV cases in 1992 is reduced by more than half In the year 2000 the 
reduction in the number of needle sharing p3rtners from L6 to I has a greater effect 
on the number of living IDV cases among the larger population sizes ofiVDUs. 
Table 4.2: Number of AIDS and IDV cases in 1992 and 2000 when condoms have 
been used 16 . .5% of the time and lVDUs share needles on average with I 
person in a year (Model A). 
%OF PEOPLE 16·24 YJ(t) Y2(t) Y3(t) Y4(t) AJ(t) A2(t) A3(t) A4(t) 
YEARS USING IVDs 
1992 1% 19 18 0 0 2 I 0 0 
2% 20 19 0 0 2 I 0 0 
3% 20 19 0 0 2 I 0 0 
2000 1% 436 324 2 3 41 32 0 0 
2% 653 526 2 3 58 48 0 0 
3% 781 657 2 3 67 58 0 0 
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Table 4.2 shows that again in 1992 there is little difference among the living number of 
infectives due to the population sizes of intravenous drug users. However, in the year 
2000 a difference does appear in the number of individuals infected. In 1992 the range 
for the total number of infected i\'fllls was between 37 and 39 with the number of 
infectives based upon the 3% estimate, being 1.05 times the number of infectives based 
upon the 1% estimate. In the year 2000 this range is between 760 and 1438 with the 
number of infectives based upon the 3% estimate, being 1.89 times the number of 
infectives based upon the I% estimate. 
Figures A4.1 and M.2 are based upon Tables 4.1 and 4.2. They show that although 
the reduction in needle sharing 'partners' does reduce the size of the peak as well as 
delaying it, the number of infectives among IVDUs is very similar after the year 20 I 0. 
It is about the year 20 I 0 when the number of infected intravenous drug users seems to 
reach a stable level. Among non-IVDUs the difference in reducing the needle sharing 
'partners' appears to be simply a delay of when the peak occur::, as by the year 2025 
only the number of infected female non-IVDUs based upon fable 4.1 has peaked. 
Figure A4.3 in Appendix 4 shows that if in 1994 the genernl behaviour of 
heterosexuals was modified and neodle sharing 'partners' were reduced to I per year, 
there is still a visible difference in the number of living infected IVDUs each year. The 
difference is. however, slight as the change in behaviour occurs about S years before 
the peak in the number of infected female IVDUs and about 10 years before the peak 
in the munber of infected male IVDUs. As the peaks occur about 25 years after the 
first infected was introduced into the population, the modifications occur when there 
are already many infected individuals. 
A graph for the comparison of the extension of Table 4.1 and the simulation of the 
behaviour modifications in 1994 of non-IVDUs was not provided as there wasn't any 
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visible difference between the two situations. This is due to the modifications being 
aimed at intravenous drug users and the spread of the mv virus among non·lVDUs is 
mainly from within the group through sexual contact. 
Table 4.3 shows that increasing condom usage from 16.5% to 35.5% of the time l;as a 
similar effect on the number of living cases of IDV infection among intravenous drug 
users, as does reducing the number of needle sharing 'partners' from 1.6 to I each year. 
There is a difference, however, in the reduction among male and female infected 
IVDUs. Reducing the number of needle sharing partners has reduced the number of 
infectives among male IVDUs to less than that whiob has resulted from increasing 
condom usage. Increasing condom usage has reduced the number of infectives among 
female IVDUs to less than the numher of infectives resulting from a reduction in 
needle sharing partners. 
Table 4.3: Numher of AIDS and HIV cases in 1992 and 2000 when condoms have 
been used 35.5% of the time and IVDUs share needles on average with 
1.6 people in a vear (Model A . 
%OF PEOPLE 16-24 Yt(t) v2(t) Y3(t) Y4(t) At(t) Az(t) A3(t) A4(t) 
YEARS USING lVOs 
1992 1% 20 17 0 0 2 I 0 0 
2% 20 17 0 0 2 I 0 0 
3% 20 17 0 0 2 I 0 0 
2000 I% 448 312 0 I 42 30 0 0 
2% 663 498 0 I 58 45 0 0 
3% 7&8 615 0 I 67 54 0 0 
Figures A4.4 and A4.5 are based upon the difference hetween Tables 4.1 and 4.3. 
They show that the increase in condom usage has a similar effect on the numher of 
infectives among intravenous drug users as does reducing the needle sharing 'partners'. 
There is a slight difference, however, in the number of male IVDU infectives after the 
year 2015 where the numbers from increase in condom usage continue to decrease 
while the number of infectives from the lower condom usage is starting to slightly 
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increase. Figure A4 .5 shows that the increase in condom usage reduces the number of 
infectives among non-IVDUs such, that it appears to be delayed by lO years. The 
number of infectives in the year 2025 from the increased condom usage is very low 
compared to that of the higher condom usage. 
Figure A4.6 show that increases in condom usage in 1994 has again a similar effect on 
the number of infected IVDUs as does reducing the needle sharing 'partners'. There is 
a slight change in the size and occurrence of the peak. Figure A4.7 shows that among 
non-IVDUs there is a significant difference in the number of infected individuals each 
year. This is due to the modifications occurring when there are only a few infected 
non-IVDUs compared to the possibility of over 400000 infected individuals, the peaks 
about the year 2020 when no modifications in behaviour occurred. 
Comparing Tables 4.2 and 4.3 shows that naturally increasing condom usage has 
resuhed in less infection among non-intravenous drug users than that from reducing 
needle sharing partners as needle sharing does not affect the spread of the virus among 
non-IVDUs. Reducing the needle sharing partners did reduce the number of living 
cases oflllV infection among non-IVDUs by nearly half in the year 2000, by reducing 
the infection among intravenous drug users. Increasing condom usage had a greater 
effect by reducing the total number of infected non-IVDUs in the year 2000 of at least 
8 (Table 4.1) to only I infected female non-IVDU. 
Table 4.4 show the results from the simulation where condoms were used 35.5% of 
the time and an intravenous drug user had on average 1 needle sharing 'partner' in a 
year. The results naturally show that there is a reduction in the number of infectives in 
both intravenous drug using groups and non-IVDUs. 
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A comparison of Tables 4.1 and 4.4 shows that reducing the number of needle sharing 
partners to I and increasing condom usage to 35.5% of the time, reduces the number 
of living IDV cases among IVDUs by about 80% in both the 1992 aod year 2000 
estimates. Tsble 4.4 shows reductions in the number of infections of over 50% from 
Tables 4.2 and 4.3 of using just one method of reducing the number ofnew infections. 
Even though the number of infections is low compared to those in Table 4.1, the rate 
of infection is high with an increase in the number of infected male IVDUs from 8 
cases in 1992 to over 150 within 8 years. 
Table 4.4: Number of AIDS and IDV cases in 1992 and 2000 when condoms have 
been used 35.5% of the time and IVDUs share needles on average with 1 
person in a year (Model A). 
%OF PEOPLE 16-24 Yt(t) Y2(t) Y3(t) Y4(t) At(t) A2(tJ A3(t) A4(t) 
YEARS USING IVDs 
1992 1% 8 7 0 0 I I 0 0 
2"/o 8 8 0 0 I I 0 0 
3% 8 8 0 0 I I 0 0 
2000 1% 151 130 0 0 13 12 0 0 
2% 172 153 0 0 15 13 0 0 
3% 181 162 0 0 15 14 0 0 
Figures A4.8 and A4.9 are based upon Tables 4.1 and 4.4. These tables also show that 
the reduction of needle sharing 'partners' from 1.6 to I a year and the increase in 
condom usage from 16.5% to 35.5% of the time greatly affects the number of 
infectives each year. The peaks of the number of infected IVDUs is reduced by over 
I 00 cases among males and over 50 cases for females. The lower peaks also occur 
about 10 years IRter tluon those oft he higher number of needle sharing 'partners' and 
lower condom usage. The number of infected non-IVDUs is very low when condom 
usage is increased and needle sharing 'partners' are reduced to less than 10000 in the 
year2025. 
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Figure A4.10 shows that reducing the needle sharing partners and increasing condom 
usage in 1994 still has a significant effect on the number of infectives among 
intravenous drug users. The peak in the number of male IVDUs infectives with the 
virus is reduced by at least I 00 cases and is delayed by less than 5 years. The number 
of living infectives decreases continuously after the peak while in the original situation, 
the number of living HIV cases started to increase slightly after the year 2015. Among 
female IVDUs the number of living infectives after the peaks have occurred fuliow a 
similar pattern of decreasing slightly before reaching what appears to be a stable level. 
The two simulations do not reach the same stable !eve~ with the modifications creating 
a level that is slightly lower than that of the original simulation. 
Figure A4.ll shows that the modifications of the behaviour in 1994 of reducing needle 
sharing 'partners' and increasing condom usage naturally reduces the number of non-
IVDUs infected given the results in Figure A4. 7. There is little difference, if any, 
between these two figures as a reduction in needle sharing 'partners' in 1994 does not 
have a visible effect on the number of infectives among non-IVDUs after an initial 
infection has occurred in tltis group. 
A further modification in 1994 was simulated. This was to increase condom usage to 
50"/o as well as the reduction of needle sharing 'partners' to I per year. Figure A4.12 
shows that among IVDUs the peak in the number of infectives is much lower and 
occurs later than without any modifications in 1994. The peaks occur at a level that is 
slightly higher than that of the eventual stable level of infectives. Figure A4.l3 shows 
that among non-IVDUs the additional modifications reduce the number of infectives 
such that they do not show up on the graph. 
A comparison of Figures A4.10 to A4.l2 is displayed in Figure A4.14 and shows that 
the increase in condom usage from 35.5% o 50% among rvDUs reduces the peaks by 
52 
i 
less than 100 cases for iofected males and less than 50 cases for females. Figure A4.15 
is a comparison between Figures A4.11 and A4. 13 and shows that in the year 2025 
there is a significant difference between the number of infucted non-IVDUs. With 
condom usage increased to 35.5% in 1994 the total number ofnon-IVDU infectives in 
2025 is over 50000 cases. The increase in condom usage to 50% in 1994 results in 
less than a total of2000 cases ofliving non-IVDU iofectives. 
4.3 Results for Model 8 
The results for model B where I iofected non-IVDU was introduced into the 
population in 1985, are in Tables 4.5 to 4.8 and are the estimated number of living 
lllV and AIDS cases for male and female IVDUs and non-IVDUs in 1992 and the 
year 2000 when I%, 2% and 3% of people aged 16 to 24 take up drugs respectively. 
The Figures A4.16 to A4.29 in Appendix 4 are the results of simulations performed on 
modeiB. 
Teble 4.5: Number of AIDS and lllV cases in 1992 and 2000 when condoms have 
been used 16.5% of the time and IVDUs share needles on average with 
1.6 plOple in a year (Original Model B). 
%0FPEOPLEI6-24 YJ(t) Y2(t) Y3(t) Y4(t) AJ(t) A2(tl A3(t) A4(t) 
YEARS USING lVDI: 
1992 1% 0 0 24 35 0 0 2 3 
2% 0 0 23 35 0 0 2 3 
3% 0 0 23 34 0 0 2 3 
2000 1% 30 26 1934 2900 2 2 153 230 
2% 59 51 1873 2817 4 4 149 224 
3% 88 76 1825 2749 6 5 145 218 
' 
Table 4.5 shows that when condoms are used 16.5% of the time and IVDUs share 
needles on average with 1.6 people in a year, introducing I infected male non-IVDU 
into the population in 1985 does not cause any iofections among IVDUs in 1992. 
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Among non-IVDUs, there are between 23 and 24 infected males and between 34 and 
35 infected females, dep..,dine upon the size of the intravenous drug using population. 
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Figure 4.2: Number of living IllY+ male and female IVDUs and non-IVDUs each 
year from 1985 to 2005 based upon Table 4.5 (I% of people aged 16 to 24 
taking up IVDUs). 
Figure 4.2 shows that when condom usage is 16.5% of the time and there are on 
average 1.6 needle sharing 'partners' in a year, that the number ofnon-IVDUs infected 
is much higher than the number of IVDUs infected. This is expected as the first 
infected was a non-IVDU. 
In tbe year 2000, the number of infected male and female non-IVDUs has increased 
drarr.atically to nearly 2000 living cases among males and nearly 3000 cases among 
females. There are also infections occurring in the intravenous drug using populatiQn 
with between 30 and 88 cases of male. living with IllY and between 26 and 76 cases 
of females living with the IllY virus in 2000, again depending upon the size of the 
intravenous drug using population. 
54 
Table 4.6: Number of AIDS and HIV cases in 1992 and 2000 when condoms have 
been used 16.5% of the time and IVDUs share needles on average with I 
person in a year (Model B). 
%OF PEOPLE 16-24 YJ(t) Y2(t) Y3(t) Y4(t) AJ(I) A2(t) A3(t) ~(I) 
YEARS USlNO JVDs 
1992 I% 0 0 24 35 0 0 2 3 
2% 0 0 23 35 0 0 2 3 
3% 0 0 23 34 0 0 2 3 
2000 1% 12 10 1934 2900 I I !53 230 
2% 23 20 1873 2817 2 2 149 224 
3% 34 30 1825 2749 3 2 145 218 
A comparison between Tables 4.6 and 4.5 shows that naturally, reducing the number .. 
of needle sharing partners does not reduce the number of infected non-IVDUs in the 
early stages of the epidemic. The only effect in the year 2000 is on the number of 
infected IVDUs. The number of infected IVDUs is reduced by more thao 500/o by 
reducing the number of needle sharing partners to I per year. 
Figure A4.16 is b:::;d upon Tables 4.5 and 4.6 and shows that the reduction in the 
number of IVDU infectives does not remain at 50% but is actually less. The difference 
is in a slightly lower peak that occurs less than 5 years later. The number of infectives 
for both simulations appear to be reaching the same level of stability. A graph is not 
provide for non-IVDUs as the difference in needle rharing partners does not create a 
visible difference. Naturally there is no visible difference for the number of IVDU 
infectives when needle sharing partners are reduced in 1994. Figure A4.17 shows the 
difference in the number of IVDU infectives when needle sharing 'partners' are reduced 
tram 1.6 to I per year. The results are very similar to those in Figure A4. 16 as the 
modifications occurred when there were only a few cases of infection among 
intravenous drug users. 
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T!blo 4. 7: Number of AIDS and HN cases in 1992 and 2000 when condoms have 
been used 35.5% of the time and IVDUs share needles on average with 
1.6 people in a year odel 8'. 
%OF PEOPLE 16-24 Y1(t) Y2(t) Y3(t) Y4(t) AJ(I) Az(t) A3(t) A4(t) 
YEARS USING IVDs 
1992 1% 0 0 8 II 0 0 I I 
2% 0 0 8 II 0 0 I I 
3% 0 0 8 II 0 0 I I 
2000 1% 3 2 175 263 0 0 15 23 
2% 6 5 171 257 0 0 15 23 
3% 9 7 168 253 I I 15 22 
Increasing condom usage from 16.5% to 35.5% has reduced the number of infections 
among non-intravenous drug users by more than 60% in 1992 and by more than 90% 
in the year 2000. The reduction among IVDUs is close to 90"/o in the year 2000. The 
number of infections among IVDUs and non-IVDUs is reduced more by increasing 
condom usage than from reducing the average nwnber of needle sharing partners. 
Increasing condom usnge from 16.5% to 35.5% has a significant effect on the munber 
ofinfectives. The delay in the peak in the number of!VDU infectives, Figure A4.18, 
is less 10 years while among non-IVDUs, Figwe A4.19, the delay in the peak in the 
number of infectives is more than I 0 years. There is a reduction in the heig.l,t of the 
peaks in both groups, but the difference is not large. Increasing condom usage in 
1994, Figures A4.20 and A4.21, produces similar effects. The main difference being 
that the delay in :lie peak in the number of infectives is not as significant, especially 
among intravenous drug users. 
Comparing Tables 4.7 and 4.8 again shows that reducing the mean number of needle 
sharing panners when I infected male non-IVDU was introduced into the population, 
does not affect the number of infected non-IVDUs. The number of infected 
intravenous drug users in 2000 has been reduced by more than 50%. 
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Table 4.8: Number of AIDS and IDV cases in 1992 and 2000 when condoms have 
been used 35.5% of the time and IVDUs share needles on average with I 
person in a year (Model B). 
%OF PEOPLE 16-24 Y1(t) Y 2(tl Y3(t) Y4(t) A1(t) A2(t) A3(t) A4(t) 
YEARS USING IVDs 
1992 1% 0 0 8 II 0 0 I I 
2% 0 0 8 II 0 0 I I 
3% 0 0 8 II 0 0 I I 
2000 1% I I 175 263 0 0 15 23 
2% 2 2 171 2S7 0 0 IS 23 
3% 3 3 168 2S3 0 0 IS 22 
Reducing needle sharing 'partners' and increasing condom usage has similar effects to 
increasing condom usage alone, though naturally more significant. This is especially 
noticeable among intravenous drug users, Figure A4.22, with the peak occurring at 
least 10 years later than for the original situation in Table 4. 5. The difference in the 
number ofinfectives among non-IVDUs, Figure A4.23 is very similar to Figure A4.19 
were the oniy change wat; that wndom usage was increased. This is again due to the 
fact that changes in needle sharing 'partners' has little if any affect on the number of 
non -IVDUs infected. 
Figures A4.24 and A4.25 are for the shnulation where condom usage was increased to 
3 5.5% and needle sharing ]partners were reduced to 1 per year in 1994. The figures 
are similar to those where the changes were made at the statt of the epidemic. They 
still show a significant difference in the number of infectives but it is naturally not as 
great as those shown in Figures A4.22 and A4.23. 
Increasing condom usage to 50% increases the delay in the peak of the number of 
IVDU infectives to nearly 20 years and again to a height that is close to the level of 
stability in the number of living HIV cases, Figure A4.26. Figure A4.27 shows that 
the delay in the number of non-IVDU infectives is such that by the year 2025 the 
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peaks have yet to occur. This is nearly 15 years after the original simulation results 
had pea-Iced. 
Figures A4.28 and A4.29 show that there is a significaot difference in the occurrence 
of the peaks between increasing condom usage to 35.5% to increasing it to 50% of the 
time in 1994. There is also a difference in the size of the peaks of IVDU infectives. 
The same cannot be said for non-IVDUs as the number ofnon-IVDU infectives when 
condom usage was increased to 50% have not peaked by the year 202'>. 
4.4 Results for Model C 
The results for model C, when I infected male IVDU, 3 infected male non-IVDUs aod 
I infected female non-IVDU were introduced into the population in 1985 are in Tables 
4.9 to 4.12. These tables provide the estimated number of living HIV and AIDS cases 
for male and female IVDUs and non-IVDUs in 1992 and the year 2000 when l %, 2% 
and 3% of people aged 16 to 24 take up drugs respectively. The Figures A4.30 to 
A4.J} in Appendix 4 are the results of simulations performed on model C. 
Table 4.9 shows that the virus can spread quickly throughout the population. In 1992 
there were between 85 and 91 intravenous drug users infected with the HIV virus 
which had not progressed to AIDS and 6 IVDUs which were infected and progressed 
to AIDS. In the year 2000 the number of living HIV cases only had increased to 
between 1032 aod 2880 living cases and the number of AIDS cases was between 112 
and 285 cases. Amoog the non-IVDUs there were between 216 and 211 cases of HIV 
infection only and 17 living AIDS cases. In the year 2000 these had increased to 
between 17387 and 16467 cases ofHIV infection and between 1387 and l315living 
AIDS cases. 
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Table 4.9: Number of AIDS and IDV cases in 1992 and 2000 when condoms have 
been used 16.5% of the time and IVDUs share needles on average with 
1.6 p)Ople in a year (Original Model C). 
%OF PEOPLE 16·24 Y](t} Y2(t) 
YEARS USING IVP1 
1992 
2000 
700 
N 
u ... 
M 
B 
E 
... R 
0 
F C4GO 
• 
LS 
E 
I S 300 
v 
I 
N 200 
G 
H 
1 100 
v 
1% 
2% 
3% 
1% 
2% 
3% 
•• 
45 40 
47 42 
48 43 
652 380 
1232 769 
1740 1140 
-Y1(T)Table4.9 
-Y2(t)Table 4.9 
-Y3(t)Tabte4.9 
-Y4(t)Table4.9 
Y3(t) Y4(t) 
87 129 
86 128 
85 126 
6978 10419 
6762 10122 
6588 9879 
.. 
YEAR 
A1(t) A2(t) A3(t) A4(t) 
3 3 7 10 
3 3 7 10 
3 3 7 10 
69 43 556 831 
124 82 539 808 
168 117 526 789 
.. 
Fieure 4.3; Number of living male and female IVDUs and non-IVDUs each year up 
from 1985 to 1995 based upon Table 4.9 (I% of people aged 16 to 24 
taking IVDUs). 
The differences in the size of the IVDU population had a significant effect on the 
number of infectives among the intravenous drug using population. The differences in 
the size of the population also affected the number of non-IVDU infectives, but not as 
significantly as that of the IVDUs. This is due to the fact that the size of the 
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intravenous drug using population •ffects the size of the pool of the suscepttbles in 
both IVDU and non-IVDU groups, more so in the IVDU as the non-IVDU population 
is very large compared to that of the IVDUs. 
The high numbers of infection among intravenous drug users is mainly attributed to the 
high probability of infection through the combination of sexual contact and needles 
sharing. The high cumbers of infection in the non-IVDU group is mainly due to the 
high nnmber of susceptibles. Figure 4.3 shows that the number of living HIV C8$0S 
among boih IVDUs and non-IVDUs is increasing dramatically between the years 1990 
to 1995. 
Table 4.10 again <hows that reducing the mean number of needle sharing partners can 
reduce the number of infections significantly. Although the reduction in the number of 
infections among IVDUs is at least SO'% in both 1992 and 2000, the number of 
infections among non-I'..-'DUs is reduced by less than 0.1%. 
Table 4.10: Number of AIDS and HIV cases in 1992 and 2000 when condoms have 
been used 16.5% of the time and IVDUs share needles on average with I 
person in a year (Model C). 
%OF PEOPLE 16-24 Y1(t) Y2(t) Y3(t) Y4(t) A1(t) A2(t) A3(t) A4(t) 
YEARS USING IVDs 
1992 1% 20 18 87 129 2 I 7 10 
2% 20 19 86 128 2 I 7 10 
3% 21 19 85 126 2 I 7 10 
2000 1% 445 327 6n6 10417 42 32 556 831 
2% 681 542 6760 10119 60 50 539 808 
3% 836 691 6585 9876 72 61 526 789 
Figure A4.30 is based upon the comparison in the number of IVDU infectives in 
Tables 4.9 and 4.10. Again the main difference is in the occurrence of the peak in the 
number of living HIV cases. The peaks occur less than 5 years after those for the 
number of infectives when there were 1.6 needle sharing 'partners' per year. The 
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difference in the height of the peak of male IVDUs is less than 100 cases and for 
females, a difference of less than SO cases between the two simulations. 
Figure A4. 31 shows that reducing needle shzring 'partners' in 1994 creates peaks in the 
number of IVDU infectives that are simply reduced in height and not so much in being 
delayed. Among female IVDU infectives, both simulations are at the same level after 
the year 2002 and reach the same level of stability of around 300 cases after the year 
2010. Among male IVDU infectives, the modified behaviour produces levels of 
infectives that is constantly slightly lower than that for the simulation of no behaviour 
modification. A graph was not provided for the differences in the simulations fur the 
number ofnon-IVDU infectives as there wasn\ any visible difference. 
Table 4.11: Number of AIDS and HIV cases in 1992 and 2000 when condoms have 
been used 35.5% of the time and IVDUs share needles on average with 
I. 6 people in a year (Model C). 
%OF PEOPLE 16-24 Y1(t) Y2(t) Y3(t) Y4(t) AI(t) A2(t) A3(t) A4(t) 
YEARS USING IVDs 
1992 1% 20 17 28 42 2 I 2 4 
2% 20 17 28 42 2 1 2 4 
3% 20 18 28 41 2 I 2 4 
2000 1% 449 313 644 967 42 31 57 85 
2% 669 502 628 946 59 46 55 83 
3% 802 624 616 928 69 55 54 82 
Increasing condom usage from 16.5% to 35.5% reduces the number of infections in 
1992 by more than 50% among IVDUs and by more than 60% among non-JVDUs. 
The reduction in the year 2000 among IVDUs is not as significant as in 1992. Among 
intravenous drug users the reduction in the number of infections ranges from tess than 
10% to less than 50%, depending upon the size of the drug using population. The 
reduction in the number ofnon-IVDUs in the year 2000 is more than 90% of the cases 
in Table 4.9. 
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Figures A4.32 and A4.33, based upon Tables 4.10 and 4.11, shows that the increase in 
condom usage creates peaks that occur later and are slightly smaller to the original 
peaks. The delays in the peaks for IVDUs is less than 5 years and the height of the 
male infectives is reduced by less than 100 and the height of the female infectives is 
reduced by less than 50 cases. Among non-IVDUs the reduction in height is less than 
25000 cases and the delays in the occurrence of the peaks is nearly 10 years. Changes 
in condom usage in 1994 still produces changes in the height of the peaks, though not 
as much for IVDUs, but the delays in the peak of the number of infectives is about 2 
years for IVDUs and 5 years for non-IVDUs. 
Table 4-12: Number of AIDS and HIV cases in 1992 and 2000 when condoms have 
been used 16.5% of the time and IVDUs share needles on average with I 
person in a_year (Model C)~ 
%OF PEOPLE 16·24 Y1(t) Y2(t) Y3(t) Y4(t) A1(t) A2(t) A3(t) ~(t) 
Y~ARS USING IVDs 
1992 1% 8 8 28 42 I 1 2 4 
2% 9 8 28 42 I I 2 4 
3% 9 8 28 41 I 1 2 4 
2000 1% 154 131 644 967 14 12 57 85 
2% 178 157 628 945 15 14 55 83 
3% 190 170 615 928 16 15 54 82 
A comparison between Tables 4. 9 and 4.12 shows that again a reduction in needle 
sharing 'partners' combined with an increase in condom usage has the greatest effect 
on the number ofinfectives and AIDS cases. The number ofiVDU infectives in 1992 
is reduced to about 1/5 of that of the original simulation and the number ofnon-IVDU 
infectives is reduced to about 1/3 of the original number. In the year 2000 these 
reductions range from about 66% to about 90% for IVDUs and for non-IVDUs the 
reduction in the number of infectives is more than 90%. 
Figures A4.36 and A4.37 show that there is a significant difference in the number of 
inrectives fur both intravenous drug users and non-IVDUs. The new peaks of IVDU 
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infectives occur after the year 2005, and at a level slightly higher than that of the level 
of stability which the numbers later reach. The new peaks for non-IVDUs occurs at 
about the year 2020, 10 years after the peaks of the original simulation. 
Reducing needle sharing 'partners' to 1 per year and increasing condom usage to 
35.5% in 1994, Figures A4.38 and A4.39, have a significant effect on the size and 
occurrence of the peaks in the number of infectives for both NDU and non-NDU 
groups. The effects are naturally not as great as those for changes in behaviour at the 
early stages of infection. If the condom usage is increased to 50% as well as reducing 
needle sharing 'partners' in 1994, Figures A4.40 and A4.41, the changes in the peaks of 
the number of infectives is very significant for both IVDUs and non-NDUs. A 
comparison between changes in condom usage to 35.5% and to 50% in 1994, Figures 
A4.42 and A4.43, show that the increase of 14.5% creates a visible difference in the 
number ofNDU infectives and non-NDU infectives. 
4.5 Discussion 
The model for the spread of the HIV virus among heterosexuals through sexual 
contact and IV drug use shows that infection from drug users to non drug users does 
eventually occur but is not significant. The same applies to the spread of the virus 
from non-IVDUs to intravenous drug users. The main significance is from infection 
within the groups. Once an individual is infected, although there may be a small start 
to the number of newly infected cases, the number of cases of new infections increases 
dramatically soon afterwards. Figure 4. 1 shows clearly that the virus has spread from 
IVDUs to non drug users and that once this transfer of infection has occurred, the 
virus spreac.ls rapidly through the non-IVDU population. 
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The difference between condom usage of 16.5% and 35.5% can be a delay of 10 years 
among non drug users and 4 years among IVDUs in the peak of the number of living 
HIV cases (Figures A4.4, A4.5, A4.18, A4.1, A4.32 and A4.33). The difference in 
condom usage also affects the size of the peak among both non-IVDUs and 
intravenous drug users. The difference between 1.6 and I needle sharing 'partners' in a 
year is only visible among the number of IVDUs infected, or when the first case of 
infuction occurred in an IVDU and the virus has spread from the IVDU group to non-
IVDUs (Figures A4.1, A4.2, A4.1 and A4.30). This indicates that accurate 
information is required if the model is to be used to predict the spread of the virus 
through the population and to estimate the number of individuals infected with the 
HIVvirus. 
Simply increasing condom usage from 16.5% to 35.5% in 1994 has a substantial effect 
on delaying and reducing the size of the epidemic among both intravenous drug users 
and non-IVDUs (Figures A4.6, A4.7, A4.20, A4.21, A4.34 and A4.35). This is due to 
the change in behaviour occurring at an early stage of the epidemic and the behaviour 
modification is occurring in both groups. Reducing the mean number of people 
needles are shared with in a year from 1.6 to I will also reduce the size of the epidemic 
as well as delay it, but this is only among IVDUs (Figures A4.3, A4.17 and A4.31). 
This is due to the behaviour modification only occurring in the IVDU group and the 
spread of the HIV virus between groups in minimal. 
The model has limitations in that it does not allow for individuals to transfer from one 
group to another. When an individual stops taking IV drugs they would normally 
transfer from the IVDU group to the non-IVDU group. The model assumed that all 
individuala would be either IVDUs or non-IVDUs for life. This ensures that the 
estimated number of infected non-IVDUs were actually infected through heterosexual 
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contact. By removing the intravenous drug users when they stop taking drugs, the 
number of cases of infection is under estimated. 
The model has other limitations in that it only concentrates on the spread of the virus 
among heterosexuals through heterosexuals, yet the virus is constantly entering the 
heterosexual population through bisexual partners and homosexual and bisexual needle 
sharing 'partners' of heterosexuals. Bisexuals provide a path for the spread of the virus 
from the homosexual population to the heterosexual population. To include these 
'partners' into the model might require the model to include the spread of the virus 
through these populations, as well as through the heterosexual population. An 
example of a model for the spread of the HIV virus throughout the entire sexually 
active population is given in Appendix 5. 
Apart from bisexuals, there are other factors in the spread of the virus through the 
heterosexual population which have not been taken into account in the modeL People 
travelling to high risk countries have a higher probability of infection, as many 
countries have higher numbers and incidences of infection than Western Anstralia and, 
therefore, probability of contact with infected individuals is greater. One method for 
introducing this factor into the model would be to consider the proportion of 
heterosexuals which travel to these ltigb risk countries and an estimate of the 
proportion of infected individuals in that country. 
Another factor in the spread of the HIV virus among heterosexuals is the presence of 
another sexually transmitted disease. The presence of S. T.O.s increases the probability 
of transmission of the HIV virus from the infected individual to the susceptible partner. 
To model this factor, an estimate of the proportion of susceptibles with S.T.D.s is 
required as they would have a different probability of transmission of the virus. 
Mathematical models are generally simplified in order to be easily adapted and 
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analysed. The more parameters or groups added to the model, the more complicated 
it becomes as shown when comparing the model used in Chapter 2 and the models in 
Appendix 5. 
In spite of these limitations in the model used, the model and results are a significant 
first step towards the understanding of the transmission dynamics of the spread of the 
IUV virus among heterosexuals in Western Australia. The model has been useful as it 
has shown that simple changes can affect the results in the inunediate future greatly. 
Some of the figures in Appendix 4 show that changes in behaviour in 1994, after the 
first infected has entered the population, still has a significant effect on the numbers of 
infected in the near future. This is due to the epidemic being in its early stages. 
Increasing condom usage had a greater effect on future numbers of infectives than 
reducing needle sharing 'partners' as it applies to both intravenous drug users and non-
IVDUs. 
The model has also shown that without any changes, such as a cure or vaccine, the 
numbers of infected individuals will remain at a high level and the situation will be that 
of an endemic rather than an epidemic . Modifications to behaviour patterns have little 
effect on this level of stability, if anything, a slight reduction in the number of living 
IUV cases (Figures A4.30, A4.40 and A4.41). 
4.6 Recommendations 
This study into the spread of the IllY virus among heterosexuals in Western Australia 
through intravenous drug use and sexual contact has shown that although studies have 
been conducted on drug users, they do not present the required information necessary 
for the execution of the proposed model. Many assumptions regarding the non-drug 
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using population were made based almost entirely on studies conducted on the drug 
using population, which accounts for less than 1% of the total sexually active 
population concerned. 
If further infonnation on the spread of the virus among heterosexuals is required, then 
studies need to be conducted not on1y on drug users, but also on the non-drug using 
majority of the Western Australian population. It is important that the infonnation 
from the study be separated into male and female respondent groups, as well as 
heterosexual, bisexual and homosexual groups. 
Infonnation on all or most of the partners would be more useful in making some 
assumptions on the chf<facteristics of the partners of the respondents, rather than 
relying on infonnation on regular partners only, as not all respondents to the 
ANAIDUS study had a regular partner and naturally the mean number of regular 
partners in a year was less than the mean number cftotal partners in a year. 
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Appendix 1 
1987 Case Defmition of AIDS 
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Fi!!!!re Al.l: Flow diagram for Centers for Disease Control case definition of AIDS, 
1987. 
(Whyte and Cooper, 1988, Figure I, page 371) 
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Tabl• Al.l: Surveillance definition of AIDS. 
INFECfiON/CANCER SITE(S) METHOD OF DEFINITE 
DIAGNOSIS 
/982 
Candidiasis O<oopho .. Histology, microsoopy, clinical 
Cryptoccw;:cosis Centni IICTVOIJS system or disseminated Histology, culture 
Crytosporidiosis Stools (diarrhoea foc ITIOf'<l than ooe JllOillh) llisW]ogy, mi~TOOCOpy 
Cytomegalovirus Other than liver, spleen, lymph nodes Histolagy, cytology 
Hefpl'$ simplex virus Mucocutaneous (citronic), lungs, gutroinlestinal Histo\l)gy, cytology, cuhure 
"'" 
Kapooi'8 sarcoma All (in peniOI1S ofless than 60 yean; of age) Histology L- Bmm Histology 
Mycobac/erium cMum Other than lung\ lymph nodes Culture 
Mycobacterium kamcuii Other than lungs. lymph nOOcs Culture 
Pnet~mocys11s carlnii 
"''"" 
Hilllolllg)', mi~ 
Progressive muttifocal Drain Histology 
leukoencephalopalhy 
Strongyloidosis Other than gastrointestirull tract Hi!.1ology 
Toxopla:smosis Other than liver, sple.:n, lymph nodes Histology, miaosropy 
1985: The above diseases plus the following with labora~ory avidence of HIV infection 
Candidiasis Bronchi, lungs Microscopy 
Histoplasmosis Dissemin.atcd Histology, cyto:ogy, culture 
lsoporiasill Oaslmintestinallra•:1 Histology, mio::roscopy 
Kaposi.IJ sarcoma All (in peniOllS of6{} yearn of age and older) Histology 
Lymphoid intestitial pna~monitis lungs (in children ofless than 13 yea111 ol'age) Histology 
Non-Hodgkin's lymphoma All Histology 
1987: All of the above diseases plus the following with laboratory evidence ofHJVinfection 
Coccidioidomycosis All Histology, mic:roscopy, cytology 
HJV encephalopathy 8111in Clinical 
HlV wasting syndrome Not appliCf.hle Clinical 
Multiple pyogenic bacteria All {in children ofless than 13 years of age) Culture 
Mycobacterium tuberculosis ,,..,..booruuy Culture 
Recurrent aalmonalial bacteraemia Blood 
""""" 
Presumptive diagnoses of 
Candidi.uis 
"""""""' 
Not applicable 
Cytomegalovirus Ey~ Not applicable 
Kaposi's sarcoma All Not applicable 
Mycobactcriolis DissaninoJ...t Not applicable 
Pneu~ocystls carlnli Lorn .. Not awlicablc 
Tmroplasmosis !lBm Not applicable 
Lymphoid buntitial pneumonitis 
""'" 
Not applicable 
e and Cooper, 1988, Table I, page 369). 
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DISEASE DEFINITIVE PRESUMPTIVE 
Candidiasis X X 
Coccidioidomycosis X 
Ccyptocol~cosis X 
Cryptosporidiosis X 
Cytomegalovirus X X 
HIV encephalopathy X 
HIV wasting gyodrome X 
Herpes simplex virus X 
Histoplasmosis X 
Isosporiasis X 
Kaposi's sarcoma X X 
Lymphoid interstitial pneumonitis X X 
Lymphoma X 
Mycobacteriosis X X 
Pneumocystis carinii (pneumonitis) X X 
Progressive muhifocalleukoencephalopathy X 
Salmonellosis X 
Strongyloidosis X 
*definitive diagnoses do not always require laboratory evidence of HIV infection. All 
the presumptive diagnoses require laboratory evidence of fllV infection. 
x = require diagnostic method. 
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Appendix2 
Program 
C WAFEX.FOR PROGRAM TEXT USING D02EBF (NAGD2 AND NAGX) 
C FORTRAN PC50 RELEASE 2. NAG COPYRIGHf 1983. 
C WESTERN AUSTRALIA 
C .. Parameters .. 
INTEGER NOUT 
PARAMETER (NOUT=6) 
C .. Scalars in Common .. 
DOUBLE PRECISION H, XEND 
INTEGER l 
C .. Local Scalars .. 
DOUBLE PRECISION TOL, X 
lNThGER !FAIL, IR, IW, J, MPED, N 
C .. Local An-.ys .. 
DOUBLE PRECISION W(l6,34), Y(l6) 
C .. External Subrootines .. 
EXTERNAL D02EBF, FCN, OUT, PEDERV 
C .. Conunon blocks .. 
COMMON XEND, H, I 
C .. Executable Statements .. 
WRJTE (NOUT,FMT=99996) 
WRJTE (NOUT,FMT=99994) 
N= 16 
IW=3~ 
MPED'~ 0 
IR=2 
DO 20 J = 10,10 
TOL = 0.100*10.00"(-l) 
WRITE (NOUT,FMT=99999) TOL 
WRITE (NOUT,FMT=99998) 
X=O.OOO 
XEND = 25.000 
C Y(l) is X 1 (0): the number of male intravenous drug using suS<x:ptibles at the start of the 
C simulation. 
¥(1)=2462.000 
C Y(2) is X 2(0): the number of female intravenoos drug using susceptibles at the start of the 
C simulation. 
Y(2) = ll87.000 
C Y(J) is X3(0): the number of male non-intravenous drug using susceptibles at the start of 
C the simulation. 
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Y(3) = 344ii54.000 
C Y(4) is X4(C): the number of fentale non-intravenous drug using susccptibles at the start of 
C ~ :;i>n11la!ion. 
Y(4) = 274475.000 
C Y(5) is Y 1 (0): the number of male intravenous drug using infectives at the stan of the 
C slm.ulation. 
Y(5) = l.ODO 
C Y(6) is Yz(O): the number of female intravenous drug using infcctivcs at the start of the 
C simulation. 
Y(6)=0.0DO 
C Y(7) is Y 3(0): the number of male non-intravenous drug using infcctives at the start of the 
C simulation. 
Y(7)=0.000 
C Y(S) is Y 4(0): the number of female non-intravenous drug using infcctives at the start of 
C the simulation. 
Y(8) = 0.000 
C Y(9) is A 1 (0): the number of male intravenous drug using AIDS cases at the start of the 
C simulation. 
Y(9)=0.000 
C Y(IO) is A2(0): the number offemale intravenous drug using AIDS cases at the start of the 
C simulation. 
Y(IO) = 0.000 
C Y( 11) is A3(0): the number of male non-intravenous drug using AIDS cases at the start of 
C the simulation. 
Y(ll) = 0.000 
C Y(l2) is ~(0): the number offemale non-intravenous drug using AIDS cases at the start 
C of the simulation. 
Y(I2) = 0.000 
C Y(l3) is Pt (0): the total nwnbcr of male intravenous drug users in the population at the 
C start of the simulation. 
Y(l3) = 2463.000 
C Y(l4) is P2(0): the total number of female intmvenous drug users in the population at the 
C start of the sirnulation. 
Y(l4) = 1187.000 
C Y(l5) is P3(0): the total number of male non-intravenous drug users in the population at 
C the start of the simulatiun. 
Y(l5) = 344954.000 
C Y( 16) is P 4(0): the total number of female non-intravenous drug users in the population at 
C the start of the simulation. 
Y(l6) = 274475.000 
H= 1.000 
1=24 
IF AIL= I 
CALL 002EBF(X,XEND,N,Y,TOL,IR,FCN,MPEO,PEOERV,OUT,W,IW,IFAIL) 
WRITE (NOUT,FMT=99997) !FAIL 
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·------- ---
IF (TOL.LT.O.DO) WRITE (NOUT,FMT=99995) 
20 CONTINUE 
STOP 
c 
99999 FORMAT (/,' CALCULATION WITH TOL=',D8.1) 
99998 FORMAT(' X AND SOLUTION AT EQUALLY SPACED POINTS') 
99997 FORMAT(' IFAIL=',ll) 
99996 FORMAT (/j/,1,' D02EBF EXAMPLE PROGRAM RESULTS',/, IX) 
99995 FORMAT(' RANGE TOO SHORT FOR TOL') 
99994 FORMAT(/,' CALCULATING JACOBIAN INTERNALLY') 
99993 FORMAT(/,' CALCULATING JACOBIAN BY PEDERV') 
END 
SUBROUTINE FCN(T,Y,F) 
C .. Scalar Arguments .. 
DOUBLE PRECISION T 
C .. Array Arguments .. 
DOUBLE PRECISION F(l6), Y(l6) 
c 
C LAMDMU is A 1: the recruitment rate for the ma1e intravenous drug using population. 
REAL *8 LAMDMU /291/ 
C LAMDFU is A2: the recruitment rate for the female intravenous drug using 
C population. 
REAL'S LAMDFU /140/ 
C LAMDMN is A3: the recruibncnt rate for the male non-intravenous drug using 
C population. 
REAL'S LAMDMN /IS662/ 
C LAMDFN is A4: the recruitment rate for the female non-intrnvenous drug using 
C population. 
REAL'S LAMDFN /15651/ 
C NMU is 111: the average number of nccdlc sharing 'partners' of a male intravenous 
C drug user in a year. 
REAL'S NMU /1.6/ 
C NFU is 112: the average number of needle sharing 'partners' of a female intravenous 
C drug user in a year. 
REAL*8 NFU /1.6/ 
C BETAHT is fJ: the probability of transmission of the virus through the sharing of 
C needles. 
REAL'S BETAHT /0.2/ 
C RHOMN is p3: the minimum proportion of male non-IVDUs that have come into 
C sexual contact with intravenous drug users. 
REAL'S RHOMN /5.0D-5/ 
C RHOFN is p4: the minimum proportion of female non-IVDUs that have come into 
C sexual contact with intravenous drug users. 
REAL*S RHOFN /3.0D-4/ 
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C Cl2 : the average number of female IVDU partners that a ma1e intravenous drug user 
C has in a year. 
REAL'S C12/2.%70/ 
C C 14 : the average number of female oon-IVDU partners that a male intravenous drug 
C user has in a year. 
REAL'S C14/1.6330/ 
C C21 :the average number of male IVDU partners that a female intravenous drug user 
C has in a year. 
REAL'S C21/7.2306/ 
C C23 : the average number of male non-IVDU partners that a female intravenous drug 
C user has ln. a year. 
REAL *S C23/0.5694/ 
C C32 : the average number of female IVDU partners that a male non-intravenous drug 
C user has in a year. 
REAL'S C32/0.0322/ 
C C34 : the average number of female non-IVDU partners that a male oon·intravenous 
C drug user has in a year. 
REAL'S C34/4.567S/ 
C C4I : the average number of male IVDU partners that a female non-intravenous drug 
C user has in a year. 
REAL'S C41/0.0312/ 
C C43 : the average nwnhcr of male non-IVDU partners that a female non-intravenous 
C drug user has in a year. 
REAL'S C43/7.7532/ 
C BET AFM is flFM: the prcCability of transmission of the HIV virus from a female 
C infective to a male susceptible tluough sex-.!al eonta.ct 
REAL'S BETAFM /0.0645/ 
C BETAFM is PMF' the probability of transmission of the HIV virus from a male 
C infe<:tive to a li:male susceptible through sexual contact. 
REAL'S BETAMF /0.1290/ 
C MUMU is J.11: the migration rate from the male intravenous drug using population. 
REAL'S MUMU /0.10417/ 
C MUFU is 1J.2: the migration rate from the female intravenous drug using population. 
REAL'S MUFU .'0.10417/ 
C MUMN is J.14: the migration rate from the male non-iotrnvenous drug using 
C population. 
REAL'S MUMN /0.02S57/ 
C MUFN is 14: the migration rate from the fcnude non-intravenous drug using 
C population. 
REAL *S MUFN /0.02S57/ 
C ALPHA is 1/a: the mean incubation period for the HIV virus. 
REAL'S ALPHA/0.17.5/ 
C DELTA is li: the death rate from AIDS. 
REAL'S DELTA /1.000/ 
C .. Executable Statements .. 
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c 
c 
c 
c 
F(l)=dX,(t) F(2'=dX,(t) F(3)=dX,(t) F(4)=dX,(t) 
dt' 'dt' dt' dt 
f(l) = LAMDMU-NMU*BETAHf*Y(l)*(Y(5)+Y(6))/(Y(I3)+Y(I4))-MUMU'Y(I) 
+ -C12*BETAfM'Y(I)'Y(6)/Y(I4)-CI4'BETAfM'Y(I)'Y(8)tY(I6) 
f(2) = LAMDfU-NfU*BETAHf*Y(2)'(Y(5)+Y(6))/(Y(I3)+Y(I4))-MUfU'Y(2) 
+ -C21*BETAMf'Y(2)*Y(5)N(13)-C23*BETAMf'Y(2)'Y(7)N(I5) 
f(3) = LAMDMN-MUMN'Y(3)-RHOMN*C32*BETAfM'Y(3)'Y(6)N(I4) 
+ -C34*BETAfM'Y(l)'Y(8)/Y(I6) 
f(4) = LAMDfN-MUfN'Y(4)-RHOfN*C41*BETAMf'Y(4)'Y(5)N(I3) 
+ -C43*BETAMf'Y(4)*Y(7)N(15) 
F(5) =<if~/), F(6)= <if:}; I), F(?) = ':t~t), F(8) = d~~t) 
f(5) = NMU'BETAHf'Y(I)'(Y(5)+Y(6))/(Y(I3)+Y(14))-(ALPHA+MUMU)'Y(;) 
+ +CI2*BETAfM'Y(l)*Y(6)N(14)+C14'BETAfM'Y(l)'Y(8)N(I6) 
f(6) = NfU'BET AHf'Y(2)'(Y(5)+Y(6))/(Y( 13)+Y( 14))-(ALPHA+MUFU)'Y(6) 
+ +C21*BETAMf'Y(2)'Y(5)/Y(l3)+C23*BETAMf*Y(2)'Y(7)N(l5) 
f(7) = -{ALPHA+MUMN)'Y(7)+RHOMN*C32*BETAfM'Y(3)'Y(6)N(l4) 
+ +C34'BETAfM'Y(3)'Y(8)N(16) 
f(8) = -{ALPHA+MUfN)'Y(8)+RHOfN*C41'BETAMf'Y(4)'Y(5)N( 13) 
+ +C43'BETAMf*Y(4)'Y(7)N(15) 
F(9) = dA,(t), F(IO)= dA,(t), F(ll) = dA,(t), F(l2)= dA,(t) 
dt dt dt dt 
F(9) = ALPHA'Y(5)-(DELTA+MUMU)'Y(9) 
f(IO) = ALPHA*Y(6)-(DELTA+MUFU)'Y(IO) 
f(ll) = ALPHA*Y(7)-{DELTA+MUMN)'Y(Il) 
F(l2) = ALPHA'Y(8)-(DELTA+MUFN)'Y(I2) 
F(L3)=dP,(t) F(14) = dP,(t) F(l5)= dP,(t) F(16)= dP,(t) 
dt' dt' dt' dt 
f(l3) = f(l)+f(5)+f(9) 
f(l4) = f(2)+f(6)+f(IO) 
f(15) = F(3)+F(7)+f(ll) 
f(l6) = f(4)+F(8)+F(12) 
RETURN 
END 
SUBROUTINE PEDERV(X,Y,PW) 
C .. Scalar Arguments .. 
C DOUBLE PRECISION X 
C .. Anay Arguments .. 
C DOUBLE PRECISION PW(3,3), Y(3) 
C .. Executable Statements .. 
RETURN 
END 
SUBROUTINE OUT(X,Y) 
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C .. Pruamet<rs .. 
INTEGER NOUT 
PARAMETER (NOUT=6) 
C .. Scalar Arguments .. 
DOUBLE PRECISION X 
C .. Array Arguments .. 
DOUBLE PRECISIONY(I6) 
C .. Scalars in Common .. 
DOUBLE PRECISION H, Xl:.ND 
INTEGER I 
C .. Local Scalar. .. 
INTEGER J 
C .. Intrinsic Functions .. 
INTRINSIC DBLE, REAL 
C .. Conunoo blocks .. 
COMMON XEND, H, I 
C .. Executable Statements .. 
WRITE (NOUT,FMT=99999) X, (Y(J),J=I,4) 
WRITE (NOUT,FMT=99999) X, (Y(J),J=5,8) 
WRITE (NOUT,FMT=99999) X, (Y(J),J=9,12) 
WRITE (NOUT,FMT=99999) X, (Y(J),J=I3,16) 
X= XEND- DBLE(REAL(I))"H 
I= I- I 
RETURN 
c 
99999 FORMAT(' ',F7.2,4D13.5) 
END 
,:,' 
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Appendix3 
Numerical Solutions to Differential Equations 
Adams Metllod (Hall and Watt, 1976) 
The non-stiff version of Gears method is based upon ABM methods (Adams-
Bashforth-Moulton methods). The ABM method is a combination of the Adams·· 
Bashforth method (AB) aod the Adams-Moulton method (AM). The AB method is ao 
explicit linear multi step method (LMM) of Adams type and the AM method is an 
implicit linear multi step method of Adams type. 
The Adams method ofk-steps, is defined by the choice of the polynomial, A 8), given 
below, to assure strong stability, through all the extraneous roots being at the origin. 
Adams-Bashforth-Moulton Method (Mathews, 1992) 
The Adams-Bashforth-Moulton method to approximate the solution of the initial value 
problem y'= j(t,y) and y(a) = y, over [a,b] is based upon the theorem, given by 
(1). 
'J' y(t,,) = y(t, )+ /(l,y{l}}dl (1) 
'• 
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The Adams-Bashforth predictor, given by (2), is based upon the integration of ( 1) over 
the interval of [1,,1.,1) and uses the Lagrange polynomial approximation for 
f(l,y(t)) for the points (t,_,,/,_3 ), (t,_,,f,_,), (1>-~,/,_1 ), and (t,,f,). 
h 
p,,, = y, + 24 (-9/,_, +37 /,_,- 59/k-1 +55/,) (2) 
The Adams-Moulton corrector, given by (3), is also based upon the integration of ( 1) 
over the interval of [tt,(h1] and uses the Lagrange polynomial approximation for 
f(t,y(t)) for the points (t,_,,j,_,), (1,_,,/,_1), (t,,j,), and (t,,.,/,,1). The new 
point (t,,1,f.,,)=(t.,,,/(l.,,,p.,1)) uses the value p,,, equated by(2). 
h y, .. = y, + 24 [/,_, -5/,_, + 19/, +9/.,,) (3) 
The algorithm for the Adams-Bashforth-Moulton method (Mathews, page 472, 1992). 
INPUT A, B, Y(O) 
INPUTN 
H :=[8-A]IN 
T(O) :=A, FO := F(T(O), Y(O)) 
FORK= 1 TO 3 DO 
T(K) :=A+ K*H 
Get Y(K) 
Fl := F(T(l),Y(I)), F2 := F(T(2),Y(2)), F3 := F(T(J),Y(3)) 
H2 :=W24 
FORK=3TON-IDO 
P := Y(K) + H2*(-9*F0+37*Fl-59*F2+55*F3) 
T(K+I) :=A+ H*(K+I) 
F4 := F(T(K+I),P) 
Y(K+I) := Y(K) + H2*[Fl-5*F2+ 19'F3+9*F4] 
FO := Fl, Fl := F2, F2 := F3 
F3 :=F(T(K+l),Y(K+I)) 
FORK=OTONDO 
PRINT T(K), Y(K) 
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{Endpoint and initial va1l;e} 
{Number of steps, N> 3} 
{Compute the step size} 
{Either input three additional 
starting va1ucs or compute them 
using the Rungc-Kutta method} 
{Saves wasted computations} 
{Predictor} 
{Next abscissa} 
(EvahU!.te f(t,y)l 
{Corrector} 
{Update the values} 
(Output} 
The Gear Method (Gear, 1971) 
The following figure provides the best description of what the Gear method is. 
Further details of this method are not provided as they are beyond the scope of this 
thesis. 
ENTR y Is this the firil cail? y., Set Order to 1J 
LNo l NumericaDy Difference to 
!Predict aJ~ Sethy;to 0 I set J acobianJ invert. • 
1 1 
I Compl<e D=H(y,y,t)+Pv . Set EVALto ·II 
I Premultipty • by invene ofJacobtans end correct.! NO 
(Are corrections small? Nn Third cornction? 
J~es y .. 
NO 
ISctEVALt<>OI (EVAL=-1? 
_l .Jy .. 
!Estimate_ !;.nor by Predictor Carrector Difference I I Reduce H by 4 
.L 
~less thanE? NO Reduce H 
Lv., 
I ~ose Onler and Step I 
Su:e for next step . 
• EXIT 
Fjgure A3.1: Flow diagram for the program organisation of the Gear Method. 
(Gear. 1971, Figure 4, page 94) 
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APPENDIX4: 
Figures of Model Results 
Table AU: .e2end for figures of results of simulations conducted. 
SIMULATION !NFECTIVE(S) NEEDLE SHARING CONDOM USAGE 
REFERENCE INTRODUCED 'PARTNERS' (%OF THE TIME) 
MODEL A: 
Table4.1 I maleiVDU 1.6peryear 16.5% 
Table4.2 I maleiVDU 1 per year 16.5% 
Table 4.3 I male IVDU 1.6 per year 35.5% 
Table4.4 I malelVDU I per year 35.5% 
MODELB: 
Table 4.5 I male non-IVDU 1.6 per year 16.5% 
Table 4.6 I male non-IVDU I per year 16.5% 
Table4.7 I male non-IVDU 1.6 per year 35.5% 
Table4.8 1 male non-IVDU I p~r year 35.5% 
MODELC: 
Table4.9 1 male IVDU 1.6 per year 16.5% 
3 male non-IVDUs 
& 1 female non-IVDU 
Table 4.10 I maleiVDU I per year 16.5% 
3 male non-IVDUs 
& 1 female non-IVDU 
Table 4.11 I malelVDU 1.6 per year 35.5% 
3 male non-IVDUs 
& I female non-IVDU 
Table 4.12 1 maleiVDU I per year 35.5% 
3 male non-IVDUs 
& I female non-IVDU 
• 
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Table A4.2: Legend for figures of results of simulations where modifications on 
behaviour patterns were made in 1994. 
SIMULATION MODIFICATIONS TO ORIGINAL MODEL • 
REFERENCE 
1994/1 In 1994 the number of needle sharing 'partners' was reduced 
from 1.6 to I per year. Condom usage remains at 16.5% of the 
time. 
1994/2 In 1994 condom usage was increased from 16.5% to 35.5% of 
the time. Needle sharing 'partners' remains at 1.6 per year. 
1994/3 In 1994 the number of needle sharing 'partners' was reduced 
from 1.6 to I per year and condom usage was increased from 
16.5% to 35.5% of the time. 
1994/4 In 1994 the num~er of needle sharing 'partners' was reduced 
from 1. 6 to 1 per year and condom usage was increased from 
16.5% to 50'/o of the time. 
• Original models are Table 4.1 for Model A, Table 4.5 for Model Band Table 4.9 
for Model C. 
A4.1 Results from Model A: 
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Fjgure A4.1: Number of living lllV+ male and female IVDUs each year from 1985 10 
2025 based upon Tables 4.1 and 4.2 (I , C ~ 16.5, P ~ 1.6/ C ~ 16.5, P ~ 
I). 
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Figure A4.2: Number of living H!V+ male and female non-lVDUs each year from 
l 985 to 2025 based upon Tables 4. l and 4.2 (N , C = 16.5, P = 1.6 I C = 
16.5, P= 1). 
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Fiaure A4,3: Number ofliving HIV+ male and female JVDUs each year from 1985 to 
2025 when needle sharing 'partners' were reduced in 1994 (l, C = 16.5, P = 
1.6/ c = 16.5, p = l (94)). 
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Figure A4,4: Number of living HIV+ male and female IVDUs each year from 1985 to 
2025 based upon Tables 4.1 and 4.3 (I, C ~ 16.5, P ~ 1.6 I C ~ 35.5, P ~ 
1.6). 
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Figure A4,5: Number of living HIV+ male and female non·IVDUs each year from 
1985 to 2025 based upon Tables 4.1 and 4.3 (N , C ~ 16.5, P ~ 1.6/ C ~ 
35.5, p ~ 1.6). 
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2025 when condom usage was increased in 1994 (I, C ~ 16.5, P = 1.6/ C 
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Firure A4.7: Number of Uving IDV+ male and female non-IVDUs each year from 
1985 to 2025 when condom usage was increased in 1994 (N, C ~ 16.5, P ~ 
1.6/ c ~ 35.5 (94), p = 1.6). 
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Figure A4,8: Number ofliving HIV+ male and female IVDUs each year from 1985 to 
2025 based upon Tables 4.1 and 4.4 (I , C ~ 16.5, P ~ 1.6/ C ~ 35.5, P ~ 
1 ). 
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Fiaure A4.9: Number of living HIV+ male and female non-IVDUs each year from 
1985 to 2025 based upon Tables 4.1 and 4.4 (N, C ~ 16.5, P ~ 1.6/ C ~ 
35.5, p ~ 1). 
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Figure A4.10: Number of living IDV+ male and female IVDUs each year from 1985 
to 2025 when needle sharing 'partners' were reduced and condom usage 
was increased in 1994 (I, C ~ 16.5, P ~ 1.6/ C ~ 35.5 (94), P ~ l (94)). 
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Figure A4.11: Number of living IDV+ male and female non-IVDUs each Y'"" from 
1985 to 2025 when needle sharing 'partners' were reduced and wndom 
usage was increased in 1994 (N, C ~ 16.5, P ~ 1.6 I C ~ 35.5 (94), P ~ I 
(94)). 
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Figyre A4.12: Number ofliving HIV+ male and female IVDUs each year from 1985 
to 2025 when needle sharing 'partners' were reduced and condom usage 
was increased to 50% in 1994 (I, C = 16.5, P = 1.6/ C =50 (94), P = I 
(94)). 
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Figure A4.13: Numbcr of living HIV+ male and female noo-IVDUs each year from 
1985 to 2025 when needle sharing 'partncrs' were reduced and condom 
usage was increased to 50'/o in 1994 (N, C = 16.5, P = 1.6/ C = 50 (94), P 
= I (94)). 
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Fiaure A4.14: Number of living HJV+ male and female IVDUs each year from I9SS 
to 2025 when needle sharing 'partners' were reduced and condom usage 
was increased to 35.5% and to 50"/o in 1994 (I, C ~ 35.5 (94), P ~ I (94) I 
C ~ SO (94), P ~ I (94)). 
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Figure A4.15: Number of living HIV+ male and female non-IVDUs each year from 
1985 to 2025 when needle sharing 'partners' were reduced and condom 
usage was increased to 35.5% and to 50"/o in 1994 (N, C ~ 35.5 (94), P ~ 
I (94) I C =50 (94), P ~ I (94)). 
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Figu"' A4.16: Number of living HIV+ male and female lVDUs each year from 1985 
to 2025 based upon Tables 4.5 and 4.6 (I, C ~ 16.5, P ~ 1.6/ C ~ 16.5, P 
~ 1). 
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Fieure A4.17: Number of living HIV+ male and female IVDUs each year from 1985 
to 2025 when needle sharing 'partners' were reduced in 1994 (I, C ~ 16.5, 
P ~ 1.6/ C ~ 16.5, P ~I (94;). 
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Figure A4.!8: Number of living HIV+ male and female IVDUs each year from 1985 
to 2025 based upon Tables 4.5 and 4. 7 (I, C ~ 16.5, P = 1.6 I C ~ 35.5, P 
~ 1.6). 
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Figul'2 A4.19: Number of living HIV+ male and female non-IVDUs each year from 
1985 to 2025 based upon Tables 4.5 and 4.7 (N. C ~ 16.5, P = 1.6 I C = 
35.5, p ~ 1.6). 
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Figure A4.20: Number of living IDV+ male and temale IVDUs each year from 1985 
to 2025 when condom usage was increased in 1994 (I, C ~ 16.5, P ~ 1.6/ 
c ~ 35.5 (94), p ~ 1.6). 
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Figure A4.21: Number of living IDV+ male and female non-IVDUs each year from 
1985 to 2025 when condom usage was increased in I 994 (N , C ~ I 6.5. P ~ 
1.6/ c ~ 35.5 (94), p ~ 1.6). 
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Figure A4.22': Number of living HIV+ male and female IVDUs each year from 1985 
to 2025 based upon Tables 4.5 and 4.8 (I, C ~ 16.5, P ~ 1.6/ C ~ 35.5, P 
~ 1). 
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Figure A4.23: Number of living HIV+ male and female non-IVDUs each year from 
1985 to 2025 based upon Tables 4.5 and 4.8 (N, C ~ 16.5, P = 1.6/ C ~ 
35.5, P = I) 
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Figure A4,24: Number of living HIV+ male and female IVDUs each year from 1985 
to 2025 when needle sharing 'partners' were reduced and condom usage 
was increased in 1994 (1, C ~ 16.5, P ~ 1.6/ C = 35.5 (94), P ~ 1 (94)). 
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Figure A4.25: Number of living HIV+ male and fumale non-IVDUs each year from 
1985 to 2025 when needle sharing 'partners' were reduced aod condom 
usage was increased in 1994 (N, C ~ 16.5, P ~ 1.6/ C ~ 35.5 (94), P ~ I 
(94)). 
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Figure A4,26: Number of living HN+ male and female IVDUs each year from 198S 
to 2025 when needle sharing 'partncrs1 were reduced and condon::. usage 
was increased to 50"/o in 1994 (I , C ~ 16.5, P ~ 1.6 I C ~ SO (94), P ~ I 
(94)). 
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Fiourt A4,27: Number of living IDV+ male and female non-IVDUs each year from 
1985 to 202S when needle sharing 'partners' were reduced and condom 
usage was increased to SO% in 1994 (N, C ~ 16.5, P ~ 1.6/ C ~SO (94), P 
~ I (94)). 
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Figure A4.28: Number of living HIV+ male and female IVDUs each year from 1985 
to 2025 when needle sharing 'partners' were reduced and condom usage 
was increased to 35.%5 and to 50% in 1994 (I. C ~ 35.5 (94). P ~I (94) I 
C ~50 (94), P ~ I (94)) . 
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Fieure A4.29: Number of living HIV+ male and female non-IVDUs each year from 
1985 to 2025 when needle sharing 'partners' were reduced and condom 
usage was im:reased to 35.5% and to 50% in 1994 (N, C ~ 35.5 (94), P ~ 
I (94) I C ~50 (94), P ~ I (94)). 
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A4.3 Results from Model C: 
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Figure A4.30: Number of living HIV+ male and female IVDUs each year ITo:n 1985 
to2025 based upon Tables4.9:md4.10 (I, C ~ 16.5, P~ 1.6/ C ~ 16.5, P 
~ 1). 
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Figure A4.31: Number of living IDV+ male and female IVDUs each year from 1985 
to 2025 when needle sharing 'partners' are reduced in 1994 (I, C ~ 16.5, P 
~ 1.6/ C ~ 16.5, P ~ I (94)). 
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Figure A4.32: Number of Jiving HIV+ male and female IVDUs each year from 1985 
to 2025 based upon Tables 4.9 and 4.11 (I, C ~ 16.5, P ~ 1.6/ C ~ 35.5, P 
~ 1.6). 
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Fig•re A4.33: Number of living HIV+ male and female non-IVDUs each year from 
1985 to 2025 based upon Tables 4.9 and 4.11 (N, C ~ 16.5, P ~ 1.6/ C ~ 
35.5, p ~ 1.6). 
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Figure A4.34: Number of living HIV+ male and female IVDUs each year from 1985 
to 2025 when condom usage is increased in 1994 (I , C = 16.5, P = 1.6/ C 
= 35.5 (94), p = 1.6). 
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Figure A4.35: Number of living HIV+ male and fefi1li!~ !':~n-lVDUs each year from 
1985 to 2025 when condom usage is increased in 1994 (N, C = !6.5, P = 
1.6/ c = 35.5 (94), p = 1.6) 
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Fig~« ~~Number of living HIV+ male and female IVDUs each year from 1985 
to 2025 based upon Tables 4.9 and 4.12 (I, C ~ 16.5, P ~ 1.6/ C ~ 35.5, P 
~ 1). 
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!Iieure A4.37: Number of living HIV+ male and female non·IVDUs each year from 
1985to 2025 based upon Tables 4.9 and 4.12 (N, C ~ 16.5, P ~ 1.6/ C ~ 
35.5, P~ 1). 
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Figure A4.38: Number of living HIV+ male and female IVDUs each year from 1985 
to 2025 when needle sharing 'partners' are reduced and condom usage is 
increased in 1994 (I, C = 16.5, P = 1.6/ C = 35.5 (94), P = I (94)). 
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Figure A4.39: Number of living HIV+ male and female non-IVDUs each year from 
I 985 to 2025 when needle sharing 'partners' are reduced and condom usage 
is increased in 1994 ( N. C = 16.5, P = 1.6/ C = 35.5 (94), P =I (94)). 
106 
700 
N 
u ... 
M 
8 HIOO 
El 
Ry 
... 
oc 
FA 
... 
LS 
E 
I S 200 
v 
I 
N 100 
G 
I 
• 
-Y1{T) Table-1.9 
-Y2(t) Table 4.9 
-Y1(t)1994/4 
-Y2l\) 1994/4 
• 0 • • 
0 • 
YEAR 
1 
0 
1 
• 
2 
0 
2 
• 
Figure A4.40: Number of living HIV+ male and female IVDUs each year from 1985 
to 2025 when needle sharing 'partners' are reduced and condom usage is 
increased to 50% of in 1994 (I, C ~ !6.5, P ~ !.6 I C ~50 (94), P ~ I 
(94)). 
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FicPre A4.4J: Number of living IDV+ male and female non-IVDUs each year from 
1985 to 2025 when needle sharing 'partners' are reduced and condom usage 
is increased to 50% in 1994 (N, C ~ 16.5, P ~ !.6 I C ~ 50 (94), P ~ I 
(94)). 
107 
-N 
u ... 
M 
BH 
E 1-
Ry 
oc,.. 
•• 
s 
LE200 
I S 
v 
I 
N 101 
G 
8 
• 
-Y1(1)1994/3 
-Y2(t) 1994/3 
-Y1(!)1994/4 
-Y2(t)1994/4 
• 
• 
8 
• 
• • 
YEAR 
1 
• 
1 
• 
2 
• 
2 
• 
Figure A4.42: Number of living ffiV+ male and female IVDUs each year from 1985 
to 2025 when needle sharing 'partners' sre redueed and condom usage is 
increased to 35.5% and to 50"/o in 1994 (I, C ~ 35.5 (94), P ~ I (94) I C ~ 
50 (94), P = I (94)). 
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Ficure A4.4J: Number of living mv+ male and female non-IVDUs each year from 
1985 to 2025 wben needle shoring 'partners' sre redueed and condom usage 
is increased to 35.5% and to 50"/o in 1994 (N, C ~ 35.5 (94), P = I (94) I 
C =50 (94), P = I (94)). 
108 
APPENDIXS: 
Epidemic Model for All Sexual Contact 
The two models in this appendix follow the same principles as those in chapter 2. The 
first model considers transmission of the virus through sexual contact only, while the 
second model al'IO includes transmission through IV drug use. As in the earlier models 
~:i(t), Yi(t), Aj(t) are the number of susceptibles, infectives and AIDS cases 
respectively which are from group i at time/. Pi(t) is the total population of group i at 
time /. The following model parameters have been used in the two models. The 
groups used in each model are listed at the start of each section. 
llmm : Probability of transmission of the HIV virus through sexual contact from a male 
infective to a male susceptible. 
llmr: Probability of transmission of the HIV virus through sexual contact from a male 
infective to a female susceptible. 
Pfrn : Probability of transmission of the HIV virus through sexual contact from a 
female inf€ctive to a male st,<eptible. 
Ptr: Probability of t<ansmission of the IflV virus through sexual contact from a female 
infective to a female susceptible. 
" P : Probability of transmission of the IflV virus through the sharing of needles. 
Aj : Recruibnent rate into group i. 
llj : Migration rate from group i. 
'li : Average number of needle sharing 'partners' which an individual from group i has 
in a year (i ~ 7 to 12). 
Cjj : Average number of sexual partners an individual from group i chooses from group 
j in a year. 
a : Rate of progression of the IflV virus. 
6 : Death rate from AIDS. 
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AS. I Transmission Through Sexual Contact Only 
Group l : All male homosexuals. 
Group 2 : All female homosexuals. 
Group 3 : All male bisexuals. 
Group 4 : All female bisexuals. 
Group 5 : All male heterosexuals. 
Group 6 : All female heterosexuals. 
~(I)_ 1;(1) f,(l) 
--":'-'--A, -P-c10X,(I)--p_c.,X,(I)--p,X, (I) dl P,(l) P,(l) 
dX,(I) 
dl 
Y,(l) 1:;(1) A, -P11c22X,(I)--- fl~HX,(I)-- p,X,(I) P, (I) P., (1) 
dX4(~=A -pc X(I)Y,(t)_,.c X(t)Y,(t)_p c X(I)Y,(t) 
dl 4 8 " 4 P,(t) ..,., . ., 4 P,(t) 8 " 4 P
4
(t) 
dX,(t) 
dt 
Y,(t) 
-f3...,c.,X4 (t) P,(t)- p4 X 4 (1) 
f,(l) 1';(1) A,- Prmc,.X,(t)--- flrmc~X,(t)-- p,X,(I) 
P.,(l) P.(t) 
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(AS.l.l) 
(A5.l.2) 
(A5.1.3) 
(A5.!.4) 
(AS.l.S) 
(A5.l.6) 
dY,(t)=fJ, c X(t)Y,(I) +fl, c X(t)Y,(t)_(a+" )Y.(I) 
dt """ II I ~(/) """ 13 I ~(t) r"] I 
dY,(t) 
dt 
Y,(t) Y,(t) PrnX,(t)-- + P,r:,.X,(I)--- (a+ p, )Y,(I) 
P,(t) P,(t) 
dY,(t) Y,(t) !',(1) f.(l) 
dt =P-c,X,(t) P,(t) +P_c,X,(t) P,(t) +Pr-c,.X,(t) P,(t) 
!;(I) 
+Pr-c36X,(t)-- (a+ p,)Y,(t) P,;(t) 
JY.(t) Y,(t) Y,(t) Y,(t) 
dt = P,r:.,X,(t) P,(l) + P.,c.,X,(I) P,(l) + P,r:.,X,(I) P,(l) 
Y,(l) 
+P,.c.,X, (1)--- (a+ p,)Y, (I) 
P,(l) 
dY,(I)=P c X(I)Y,(I)+P c X(t)Y,;(I)_(a+n )Y.(I) 
dl r- " ' P,(l) f• so l P,(l) rl l 
dY,(I)=a c X(t)Y,(I) +P.c X(l/,(l)_(a+u )!:(1) dt P"" 6l 6 ~(t) ""~6s 6 P
5
(t) r-6 6 
dA, (I) = aY,(I)- ( 8+ p;)A,(I) 
dl 
P,(t) = X,(l)+ f;(l)+ A, (I) 
fori= I to6 
Ill 
(A5.1.7) 
(A5.1.8) 
(A5.1.9) 
(AS.I.IO) 
(AS.I.l!) 
(A5.1.!2) 
(AS.I.IJ) 
(A5.1.14) 
A5.2 Tran§mission Through Sexual Contact and IVD Use 
Group I : Male homosexual non-IVDU. 
Group 2 :Female homosexual non-IVDU. 
Group 3 : Male bisexual non-!VDU. 
Group 4: Female bisexual non-IVDU. 
Group 5 : Male heterosexual non-IVDU. 
Group 6 : Female heterosexual non-IVDU. 
Group 7 : Male homosexual!VDU. 
Gmup 8 : Female homosexuai!VDU. 
Group 9 : Male bisexual IVDU. 
Group 10: Female bisexual!VDU. 
Group II : Male heterosexual!VDU. 
Group 12 : Female heterosexual!VDU. 
dX.,(I)_/\ -fl c X(I)Y,(t)_a c X(t)Y,(t)_R c X(t)Y,(t) 
dt - L - '·' L ~(I) "- '·' L P,(l) "- L.l L P,(t) 
Y,(t) 
-fl_c,.,X,(t) P,(t)- p,X,(t) 
dX2(t)~l\ -fl X(t)Y2(t)_p X(t)!;,(t)_p c X(t)Y,(t) 
dt 2 ffC2.2 2 P,(t) !I'M ' P.,(t) ff " ' P,(t) 
-{Jr,,X,(t) ~:~:~- p,X,(t) 
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(A5.2.1) 
(A52.2) 
(AS.2.3) 
dX4(I)_A -p X(I)Y,(I)_a X(I)Y,(I)_{J X(l)l';(l) 
dl - 4 If'., 4 P,(l) P.,f'4,5 4 P,(l) :UC4A 4 P4(1) 
" X ( ) Y,(l) fJ X() f,(l) a X() Y,(l) 
-P.,C4,s 4 I P,(l)- :UC4.• 4 I P,(l) -,-_,c4,, 4 I P,(l) (AS.2.4) 
fJ X()Y,,(I) fJ X()Y,,(I) X() 
- Jf'4,w 4 I P.,(l)- .,C4,11 4 I P.,(l) -p4 'I 
dX,(I) =A -p c X (I) Y,(l) -{J c X (I) Y,(l) -p c X (I) Y,,(l) 
dt 5 fm 5,4 .5 ~(/) /"' .\6 s ~(/) fol .5.10 s ~o(l) 
-{J'"c"'X,(I) ~: ~:~- p 5X5(1) 
(A5.2.5) 
dX,(t)- A -" X (I) Y,(l)-" X (I) Y,(t)- a X (t) Y,(l) 
dt - ' v,.C., ' P,(t) p.,f'., ' P,(t) P,.Co.• ' P,(t) 
" X( )Y;,(t) X''' 
-,...,r6.Ll 6 I ~~(/) -p6 6\'l 
(AS.2.6) 
dX,(I)- A - R c X I f,(l)-" c X (1) f,(l)-" c X (I) Y,(l) 
d/ - 5 "- S,l ,( ) .P,(I) P- S,S 5 P,(/) l'mm 5'5 5 P
5
(1) 
" r,(t) , .Lr.<t> 
-P-c,X,(t)---1'/1 fJX1(t) ,_, " - p,X,(t) 
. P,(t) l:I~(I) 
(AS.2.7) 
·~1 
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dX8(I)- A -p c X (I) Y,(l) -p c X (I) J:;(!)- p c X (1) f,(l) 
dl - 8 ff " 8 P,(l} ff " 8 P,(l) JJ 8,8 8 P,(l) 
dX,(I) A _a c X(I)Y,(I)_a c X(I)Y,(I}_p c X(l)f..(l) 
dl ' ,.._ '·' ' P,(l} ,.. •• '·' ' f\(1) 1'" '·' ' P,(l) 
P x;() Y,(l) {J, X() Y7(1) , X() Y,(l) 
- fotc9.6 t P6(t)- mmc9,7 9 I P7(t)- p.,,c9,9 9 I ~(I) 
P X ( Y,,(l) p X ( Y,,(l) - c 1)--- c 1)--fm '·" ' P. (1) fm '·" ' P. (I) \0 12 . 
" 
, 1:Y.(Il 
-.,,pX,(I) 1' 7 12 - p,X,(I) 
l:J-:(1) 
i"'7 
dXw(l)- A fJ X (I)Y,(I) R X (I)Y,(I) p X (l}f,(l) 
dt - Jo- .uC10.2 10 ?z(t) -p.,r10.3 10 ~(/)- fto.4 10 P
4
(/) 
_a X (I)Y,(I)_p X (l)f,(l) _a" X (I)Y,(I) 
1-'",.gCJo,s 10 P
5
(/) :OCw,R 10 Pg(t) l-'m/"10,9 10 ~(/) 
P X ( )Y,,(I} p X ()Y,,(I} 
- .oCto,Jo 10 I ~o(l)- ... ,Cw.u 10 I ~~(I) 
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(A5.2.8) 
(A5.2.9) 
(A5.2.10) 
(A5.211) 
dX,2(I)- A -" c X I Y,(l) -{3 X 1 Y,(l)- R X I Y,(l) 
dl - 12 ""' "·' ,() P,(l) "'""·' ,( ) P,(l) """'"·' ,() P,(l) 
" 
f,,(l) ' ~Y,(I) 
-P.,.c,.11 X,(I)-P. ( )-- 17,f3X,(I) " - tt,X,(I) 
u I L/~(1) 
too7 
df,(l)_a X(I)Y,(I)+" c X(I)Y,(I)+" c X(I)Y,(I) 
dl - f'mmCl,l 1 ~(I) "- CJ 1 P,(l) Pmm 1,7 1 P,(l) 
Y,(l) 
+f3 •• c.,X, (I)--- (1z+ ,u, )f, (I) 
P,(l) 
df,(l) - f3 X (I) Y2(1) +fJ X (I) Y,(l) +{3 X (I) f. (I) 
dl - 'n"" 2 P2(1) 'n"" 2 1',(1) gc., 2 P,(l) 
+f3gc"0 X,(I) ;.:i:i- (a+ ,u, )Y,(I) 
df,(l) A X() f,(l) p X() Y,(l) fJ X() Y.,(l) 
----;J/= "'"'cl,l 3 I ~(I)+ _cl,l l I~(/)+ ftrtc3.4 l I f'.,(l) 
+{3 c X (I) Y,(l) +" c X (I) Y,(l) +{3 c X (I) Y,(l) 
fm 3,6 3 ~(/) Pmm 3,1 3 /~(/) mm 3,9 J ~(/) 
+f31.c31,X,(I) Y,,(l) + fJ,.c,X,(t) Y,2(l) - (a+ p,)Y, (I) 
. P,,(l) . . /~2(1) 
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(A5.2.12) 
(A5.2.13) 
(A5.2.l4) 
(A5.2.15) 
dJ'..(t)_(J X(t)Y,(t)+" X(t)Y,(t)+P X(t)Y,(I) 
dl - )JC,,, ' P,(l) ,_...,c,,, • P,(l) r:... . 1':,(1) 
a X() Y,(l) p X() Y,(l) a X ( ) Y,(l) 
+,_.,c,,, 'I .P,(I) + r•.• 'I P,(l) +y,C,,o 'I P,(l) (A5.2.16) 
+Poc.,,X, (I) Y,,(l) + P..,c.,X,(I) Y,, (I) - (a+ p, )Y., (I) 
. P,,(l) . P,,(l) 
dY,(t) (J X Y.,(l) (J X( !;(I) p X( )Y,,(I) 
dl = fmc,_. ,(1) 1':,(1) + fo.CS.o ' I) P,;(l) + fo,C'·" ' I P,,(l) 
+fJ1.c,,X,(I) Y,,(l)- (a+ p, )Y,(I) 
. P,,(l) 
(A5.2.17) 
Jl;(t)_p X(I)Y,(t)+(J X(t)Y,(I)+" X(t)Y,(I) 
dl - •f"<J ' P,(l) ..r'o.s ' P,(l) ",C" ' P,(l) 
+fJ,c..,X,(t) Y,, (I)-( a+ p,)Y,(I) 
P,,(l) 
(A5.2.18) 
dY,(t} (J X( Y,(t) a X( Y,(l) a X( )Y,(I) 
dt = ,h.~ 1 t) ~(/) +1-'-cl,l 1 I) ~(t) +p_c1,1 1 t ~(I) 
[" Y,(l) ' ~f,(l) +fJ •• c,,,X,(I)--+ "' PX,(I) - " - (a+ p, )Y,(I) P,(l) :LP.(I) 
1'>1 
(A5.2.!9) 
dY,(t) (J X () Y,(t) (J X ) Y,(l) p X ( ) Y,(t) 
dt = )JC., ' I f',(l) + ff"., ,(I f\(1) + if'•.• ' I P,(l) 
[ 
12 l Y,,(l) ' ~Y,(t) 
+fJ)JC.,,X,(I)--+rJ,PX,(I) - " -(a+p,)Y,(I) 
P,, (I) LP,(I) 
kl 
(A5.2.20) 
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dY9 (I) = R c X(I)Y,(I) +fJ c X(t/•(l) +fJ c X (I)Y.,(I) 
dl ~'- 9,1 9 ~(I) ~ 9,3 9 P,(l) fm 9,< o P.,(l) 
+P c X (I) Y,(l) +{J c X (I) Y,(t) +P c X (I) Y,(t) 
fm 9,6 9 ~(/) nrm 9,7 9 P
7
(f) "'"' 9,9 9 /;(/) 
P X ( )f,,(l) p X ( )!),(1) + fmc9,\0 9 I P. (I)+ fmc9.12 9 I p (I) 
\0 •J2 
+'f19 PX9 (1 '"' 12 -<a+p9 JY,<tl {
h(t) 
L~(tl 
r~7 
df,0 (1) _ p X () Y,(l) p X () Y,(t) p X () Y.,(t) 
dt - n-Cw.2 to I Pz.(t) + ...,C,o,l 10 I ~(t) + .DctoA !O I ~(I) 
+" c X (I) Y,(l) +P X (I) Y,(t) +P c X (I) Y,(t) 
f'mj IO,S 10 ~(/) uCw.R \0 Pg(f) nlj Hl,9 10 ~(I) 
p X ()Y,,(t) fJ X ()!),(1) 
+ gCJo,to 10 / ~o(t) + ~10,\l 10 I ~~(/) 
12 
A LY,(I) 
+'f110 fJX10 (1 '"' " -(a+ p 10 )!),(1) 
LP,<tl 
;~1 
df, 1(t) -p X ) Y,(l) X Y,(t) p X Y,,(t) 
- c I --+ c I --+ c I --dt fm "·' u( P.,(l) Pr. "·' u( ) f'o(l) I• 11.10 u( ) /~,(I) 
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(A5.2.2I) 
(A5.2.22) 
(A5.2.23) 
dY,,(t) R X () Y,(t) R X ( ) Y,(t) f3 ( Y,(t) 
dt :::p"'fc\2) 12 t ~(t) +pm~C•z.s 12 t ~(t) + 111/c12.9xl2 t) ~(t) 
" 
Y,,(t) ' ~Y,(t) 
+f3 ... c,,X,(t)--+ TJ,f3X,(I) , 
. P,,(t) L;P,(I) 
-(a+ p, )Y,, (t) 
d4,(t) ~ aY,(t)-(o+p,)A,(t) 
dt 
P,(t) ~ X,(t) + Y,(t} +A, (t) 
fori~ I to 12 
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(A5.2.24) 
(A5.2.25) 
(A5.2.26) 
